ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000257.1|Prodigiosin_4 # 2580 # 2906 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.706	BGC0000257.1|Prodigiosin_4 	2580	2906	-	Loose	750	25.7942	patA	26.39	3000024	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGACACCATCGTCCACCGCATCCGCCTGCGTGACGGCGTACCGCCGGAGCGCTTCGAGCGCTGGGTGCGCGAGACCGACTACGCCACCTGCCCCGAGCTGCCCAGTGTGCTGCGCTTCTCCGTGCACCGGGTCCCCGCGGCGCCGCCCGGCGCGCCGTACCACTCCTTCGAGTTCTTCGAGATCATCGAGGTCAGCAGCCAGGACGCGTTCGCCCGCGACATGGCATCGGACGCCTTCCGGCGGCTGGAGAAGGACTTCGACACGATGGCCGAGGTGACCGACGAGCTCACCGGGCGCCGCATCGGCGCGGGCTACGCCGCCTGA	MDTIVHRIRLRDGVPPERFERWVRETDYATCPELPSVLRFSVHRVPAAPPGAPYHSFEFFEIIEVSSQDAFARDMASDAFRRLEKDFDTMAEVTDELTGRRIGAGYAA	MLIQKIKTYKWQALASLLMTGLMVASSLLQPRYLQEVLGALLTGKYEAIYSIGAWLIGVAVVGLVAGGLNVVLAAYIAQGVSSDLREDAFRKIQTFSYADIEQFNAGNLVVRMTNDINQIQNVVMMTFQILFRLPLLFIGSFILAVQTLPSLWWVIVLMVVLIFGLTAVMMGMMGPRFAKFQTLLERINAIAKENLRGVRVVKSFVQEKEQFAKFTEVSDELLGQNLYIGYAFSVVEPFMMLVGYGAVFLSIWLVAGMVQSDPSVVGSIASFVNYLSQIIFTIVMVGFLGNSVSRAMISMRRIREILDAEPAMTFKDIPDEELVGSLSFENVTFTYPMDKEPMLKDVSFTIEPGQMVGVVGATGAGKSTLAQLIPRLFDPQDGAIKIGGKDIREVSEGTLRKTVSIVLQRAILFSGTIADNLRQGKGNATLFEMERAANIAQASEFIHRMEKTFESPVEERGTNFSGGQKQRMSIARGIVSNPRILIFDDSTSALDAKSERLVQEALNKDLKGTTTIIIAQKISSVVHADKILVLNQGRLIGQGTHADLVANNAVYREIYETQK	19.15	gnl|BL_ORD_ID|1907|hsp_num:0	2081			480	696	ciprofloxacin; norfloxacin
BGC0000257.1|Prodigiosin_6 # 4184 # 6898 # -1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=CCGGA;rbs_spacer=13bp;gc_cont=0.777	BGC0000257.1|Prodigiosin_6 	4184	6898	-	Loose	200	27.7202	sdrM	30.51	3007013	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGGAATCGCGGCACTCTATCCGCGCGCGCAAGGAGTGGACCGGTACTGGCGATTCCTGACCGAATTCCTGCCGGAATCCGGCGCACCGGCGCCGGAGCACCGCTCGCTGGCCGATATCGCCGACCACGAGGTCGATGTGGCCGCCTTCGGCATTCCGCCGGCCCAGGCGGGGTCGATGGCCCGCATGCAGCTGCTGATGCTGGAGGCCGCCCGGCAGTGCCTCGCCGACGCGGGCCACCCCGGGCGCCCGCTGCCCGCCGACCGCACCGACGTGCTCACCGGTACCTGCTTCGGGCTCGACCGCCAGTACGCCAACGCGCTGCGGGTGGAGGGCAGCAGGTACGCCCGCGAGCTGGAGCGGGCCGCCTCGTCGGAGGAGGCCGGCGCCCAGCTGCGGCAGCTCCTGCTGGACCGGCTGGGCGGGTCCCCGCACGACCGGGTCGGCGAGATGGCCAGCACCATCCCGGCCCGGATCGCCACGGCCTTCAAGCTGCGTGGCCGGGCGCTGGCGCTGGAGTCCGCCGACGCGACCTCCGTACTGGGCATCGCGCAGGCGGTGCACAGCCTGCGGGACGGCTCGGCGGATGCCGCCCTGGTGCTGGCGGGGCAGCTGCGGGAGAACCCGCTGCTCCCCGCGGCCCTGGCCGCCAAGCAGGCGGCGGACGGCCGCAGCGGCGGGACACTCGGCGAGGGCGTCGGGGCCGTGCTGCTCAAGCGGCTGTCCTCGGCGGTGGCGGACGGCGACCGGGTGTACGCCACTCTCAGGGCGTGCGCCGTCCGGCACGCGCCGCGCCCGGGCGTCTTCCGCCACCCGGCGGCGCCGGGGGCGCGCCGGGCCACGGCGCGCGCGGCCTGTGCGGCGGCCGGGGTGCCGGACGCCTCGGTCCGCTACGTGGAGTGCACCGGCTCCGGCGCGCCGCACGAGACGGCGGCCGAGCAGGAGGCGTTCGGCGGCACGGCCACCGTCACGCTGGGCAGCGTGCGGGACCGGCTGGGCCACACCTTCGCCAACGCCGGGATGGCCGCGCTCACCAAGGTGGCGCTGGCACTGCACCACCGCAGCATCCCGGCGCCCGGCACGGCCCGGGACTGGCCCGCGGACCCCGGCGGCGCGCCGCGCCGCGCCGCCGTCAGCGGCGCCTCACTGACCGGGACGCTCAGCCATCTGCTGCTGGAGGAGTACGTGCCGCCCGCCGCCCCGGCGGCGGCCACGGGCCGGGCCCCCCGCTCGCGCACCGCGGCGCGGACGGAGGCCGCCGCCGAGCCGATCGCGGTGATCAGCTACGGCGCCCGTTTCTCCGGCGCGCCCGACGCGGACAGCTGCTGGCAGGCGTACCTCTCCGGCCGCGACCGGATCGGGCCGCTGCCGCCCGCCCTGCTCGACCGGGACCTGTACCACGCCCCCGGCGCGCTCAGCTTCAGCCACGCGTACACCGACCACGGCTCCCCCGTCACCGTCCCCGACCGCCCGCCGCCGGGCCTGTCCCTCACCCCGGAGCGGTACGCCGCGCTGGACCCGGCGCAGCGCGTCGGGCTGGCCGTGGCCGCCGAGGTGCTGTCCGGGCACCGGCCCGGCGCGCCCGGCCTGACCGGGGCCGGGCTGATCGCCGTCGGCTCCAGCCTCGGCCTCGGCCGCGACCGTCTCGCGGGCGCCCGGCACGGGCTGCGCGCCCTGGAACCGGAGTTCGCCCGGCTGCCCGCGCTCGCCCGGATGTCCGCCGCCGACCGGGAGAAGCTGCTCGACCTGGTGCGCGAGCGGTACGCGGCGGCCACCGCCCAGGACGGCGCGGGCGGCGCGGGCGGCACGGACGGCGGGCACAGCCCGGACGACGCGGCCGGCCCCGGCGGGGGCACCCTGGACGGCTGGCTGGCCAGCGGCACGGCGGCGCTCATCGCCGGCGAGTACGGCCTGTCCGCCACCCCCGTCGCCGTCGAGGCCGCCTGTGCGTCCTCGCTGGCGGCCCTCGACCTGGCCGCCGGGCAGCTGCGGGCCGGCTCCGTCGACTACGCCCTCGCGGGCGGCGTCGAACTGCCCTGCAACGCCAGGGACATGATCCTGTGCTGCTCGCTCGGCCTGCTGTCCCGCACCCGGATCACCCCGTTCGACTCCGCCGCCGACGGGTTCACCCCCGGCGACGGCTGCGCCCTGTTCCTGCTCAAGCGCTACGCGGACGCCCGCAGGGACGGCGACCCCATCCTGGGCGTGCTGCGCGGCATCGGCGCGTCCAACGACGCCAAGTCCCTGATCGCACCGGACACCGACGGCCAGGCAAGGGCGATCCGGCGCGCCTTCGCCCAGGCAGGGGCGGACTTCCCGCCCTCCTCGGTGGACTACCTGGAGGCGCACGGCACCGGCACGCAGGTCGGGGACCGGGTGGAGATCGCCGCCGCCGCCCGGGTGTACGCCGCGCCGGAGCGGACCCGTCCGCTGGAGGTCGGCTCGGCCAAGTCCTTCTTCGGGCACACCTTCGCGGCGGCGGGCAGCGCGGGGCTGCTGCGGGTGCTGCTGGCCCTGAAGGCCGGGACGCTGCCCCCGAACACCAATCTGCACCGCCTCAACCCCGCGCTGGGCCTGGCCGCCGTGCCGGCCGCGGTGTCCACACAGGCGGCCCCCTGGGAGCCGGTGGCCGGGCGCCCCCGCCGGGCGGCGGTCAGCTCCTTCGGTACCGGCGGCATCAACTACCACCTGCTCGTCGAGGAAGGTCCGCGATGA	MGIAALYPRAQGVDRYWRFLTEFLPESGAPAPEHRSLADIADHEVDVAAFGIPPAQAGSMARMQLLMLEAARQCLADAGHPGRPLPADRTDVLTGTCFGLDRQYANALRVEGSRYARELERAASSEEAGAQLRQLLLDRLGGSPHDRVGEMASTIPARIATAFKLRGRALALESADATSVLGIAQAVHSLRDGSADAALVLAGQLRENPLLPAALAAKQAADGRSGGTLGEGVGAVLLKRLSSAVADGDRVYATLRACAVRHAPRPGVFRHPAAPGARRATARAACAAAGVPDASVRYVECTGSGAPHETAAEQEAFGGTATVTLGSVRDRLGHTFANAGMAALTKVALALHHRSIPAPGTARDWPADPGGAPRRAAVSGASLTGTLSHLLLEEYVPPAAPAAATGRAPRSRTAARTEAAAEPIAVISYGARFSGAPDADSCWQAYLSGRDRIGPLPPALLDRDLYHAPGALSFSHAYTDHGSPVTVPDRPPPGLSLTPERYAALDPAQRVGLAVAAEVLSGHRPGAPGLTGAGLIAVGSSLGLGRDRLAGARHGLRALEPEFARLPALARMSAADREKLLDLVRERYAAATAQDGAGGAGGTDGGHSPDDAAGPGGGTLDGWLASGTAALIAGEYGLSATPVAVEAACASSLAALDLAAGQLRAGSVDYALAGGVELPCNARDMILCCSLGLLSRTRITPFDSAADGFTPGDGCALFLLKRYADARRDGDPILGVLRGIGASNDAKSLIAPDTDGQARAIRRAFAQAGADFPPSSVDYLEAHGTGTQVGDRVEIAAAARVYAAPERTRPLEVGSAKSFFGHTFAAAGSAGLLRVLLALKAGTLPPNTNLHRLNPALGLAAVPAAVSTQAAPWEPVAGRPRRAAVSSFGTGGINYHLLVEEGPR	MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE	202.24	gnl|BL_ORD_ID|4659|hsp_num:0	5729			1113	1284	norfloxacin
BGC0000257.1|Prodigiosin_9 # 8450 # 10795 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=ACCG;rbs_spacer=15bp;gc_cont=0.725	BGC0000257.1|Prodigiosin_9 	8450	10795	-	Loose	1280	40.817	macB	24.0	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAACCGCATCATGCTCCTCAAGACCCGGCGCGACGTGCGCCGGCGTCTGCCGCAGTTCGCGGCGATCGCGGTCACCGTGATGGTCGGGGTGCTGCTGTTCGTCGCGAGCTACGACGCCTACCGGAACCTCGCCGCCTCGTACGACGAGACGTACTCCCGGCTGCACTTCGCGGACCTCACCGCGTCCGGCGGCGACCCGGAGAAGGTCGCCGCGGCCGTCCGCGGCGAGCGCGGCGTCACCGGTGTCACCGCACGGCCGCAGGCCGACCTGGCGATGGAGATCAGCGACGACAAGCTGGCCGGACGGCTGATCGGGATGCCCGGTGAGGGGGAGCCCGAGGTCAACCGGGTGGATGTGACCGAGGGCGAGGGGCTCAGCCCCGGCGCCCCCGGCGGCGTGCTCGTCGAGCGGCACGCCGCGGACACCTGGGACCTGTCGCCGGGCGACAAGCTCAAGGTGTTCGACGGCTCCGCCTGGCAGTCCGTCACGGTGCGCGGGGTGGCCGTCTCCGCCGAGTACCTGTGGCCCGCCCCCAGCCGCCAGGAGGTGCTGGGCGATCCGCACTCCTTCGCGGTGGTGTTCGCCACCGAGGAGACCGCGCGCGCACTCGCCGGTGACCGGGCCACGCCGCAGACGCTGGTGCGGCTGTCGGACGACGCCTCGGCGGGCGCGGTGACCGAGCGGCTGCGCGAGGCGGGCGCGCTGGATGTGCTCAAGAAGAAGGACCAGCCGTCCAACGCCACCCTGCACGAGGACCTGAAGGGCTTCGAACAGCTCGCGCTGGGCTTCCCCGTGCTGTTCCTGGCCGCCGCAGCCATCGCAGCGTATGTGCTGATCACCCGCCTGGTGCTGTCCGAGCGGAAGGTCATCGCCACCTTCCTGGCCGCCGGTGCCCCGCGCGGTGCCATCGTCCGGCACTACCTGGGCCACGGCATCCTGGCCGGCACGGCCGGGGCCGTCATCGGCCTGGTCCTCGGCACGGTGGCCACCTCCGCGGTCACCAGGGCCTACACGAACGGCCTGGACATCCCGGACACCGTGGTGGAGCACCGGCCGCTGGTGGCCGTGACGGGCCTGCTCTTCGGCCTCGTCGTCGGCCTCGCGGGCGGTTACGCCCCGGCGCGCTCGGCGTCCAGGGCGGCGCCCGCCGAGGCGATGCGCGGCGACGTGGGCACCCTGAAGCCGCCGGGCCCGTGGAGCCGCGCGGTGGCCAGGGCCCGGCGGCTGCCGGTCACCACCCGGATGGCGCTGCGCGAACTGACCCGCAGCCGCCGCCGTACCGCGGCCACCATGACGGGCACGGTGCTGGCGCTGATCCTGGTGCTCGCCTCCGTCGGCATGATCACCAGCATGACGGCGCTGATGGACACCCAGTTCGACAAGGTCCAGAAGCAGGACGCCACGGTGACGGCCGATCCCCGCGCCGGTGACCTGGCCGAACAGATCGGCGCGGTCCGCGATGTCGGTGAGGTCGAGCGGATCACCCAGGTCCCGGCGACGGTGACGGCCGAGGGCTCCTCGTACTCCACCTCGCTCACCGGTTTCCGCCCCGGCACCAGCATGCACGGCTTCCGCACGGACGACGGCGGCACCCGGAAGCTGCCGGAGGACGGCATCCTGGCCGGCAAGGCCCTCACCGACAAGCTGGATGTCGCCGTCGGCGACTCGGTCACCGTGCACACGCGCGACGGCAAGGAGCGGAAGGTACGGCTGGCCGGGCTGGTGGAGGAGCCGCTGGGCACCGCCCTGTACGGCACCCGGGACACCGTCCCGGAGATCTCCGGCATCGACGGCAACGCCTACCAGCTGCGTTTCGACGGCGACCTGGGTACCGACGCCCGGGACACGGCGCGTTCGGCGGTGACCGGCATCGAGGGCGTGGTGGCGTACACGGACGAACAGGCGCTGCGCCGCCAGCTGGACAAGTTCCTCGCGCTGTTCTGGATCTTCGCCGGGGTGATGCTGGTGCTCGGCGGCGTGCTCGCGCTGACCGTGATCTACGTGACGATGACCGTCAACGTCGCCGAACGCAGCGGCGAGCTGGCCACCCTGCGGGCGGCCGGGGTCTCGCTGCGCCGGGTCGCCGGCGTGCTGGCCACGGAGAATCTCACGGCGACGCTCATCGCGGTGCCGATCGGTCTGGCCCTCGGCGCGGTCACGGCGTACGAATCGCTGCGCGCCTTCGACAGCGACATGTTCACCATCGAGCTCTCGCTCGGCTGGCCGGTGCTGCTGGCCGCGACGCTGGCGGTGCTGCTGGCCTCGCTGCTCTCCCAGGTGCCGGCCGTGCGTATGGTGCGCAGGCTGGACATCGCCAGGGTGGTGAGGGAACGGGCGCAATAA	MNRIMLLKTRRDVRRRLPQFAAIAVTVMVGVLLFVASYDAYRNLAASYDETYSRLHFADLTASGGDPEKVAAAVRGERGVTGVTARPQADLAMEISDDKLAGRLIGMPGEGEPEVNRVDVTEGEGLSPGAPGGVLVERHAADTWDLSPGDKLKVFDGSAWQSVTVRGVAVSAEYLWPAPSRQEVLGDPHSFAVVFATEETARALAGDRATPQTLVRLSDDASAGAVTERLREAGALDVLKKKDQPSNATLHEDLKGFEQLALGFPVLFLAAAAIAAYVLITRLVLSERKVIATFLAAGAPRGAIVRHYLGHGILAGTAGAVIGLVLGTVATSAVTRAYTNGLDIPDTVVEHRPLVAVTGLLFGLVVGLAGGYAPARSASRAAPAEAMRGDVGTLKPPGPWSRAVARARRLPVTTRMALRELTRSRRRTAATMTGTVLALILVLASVGMITSMTALMDTQFDKVQKQDATVTADPRAGDLAEQIGAVRDVGEVERITQVPATVTAEGSSYSTSLTGFRPGTSMHGFRTDDGGTRKLPEDGILAGKALTDKLDVAVGDSVTVHTRDGKERKVRLAGLVEEPLGTALYGTRDTVPEISGIDGNAYQLRFDGDLGTDARDTARSAVTGIEGVVAYTDEQALRRQLDKFLALFWIFAGVMLVLGGVLALTVIYVTMTVNVAERSGELATLRAAGVSLRRVAGVLATENLTATLIAVPIGLALGAVTAYESLRAFDSDMFTIELSLGWPVLLAATLAVLLASLLSQVPAVRMVRRLDIARVVRERAQ	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	121.27	gnl|BL_ORD_ID|446|hsp_num:0	487			1374	1932	erythromycin
BGC0000257.1|Prodigiosin_10 # 10800 # 11567 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=ACC;rbs_spacer=15bp;gc_cont=0.710	BGC0000257.1|Prodigiosin_10 	10800	11567	-	Loose	1280	184.496	macB	39.0	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGCGCCCGGCACAGGAAGGCGATCCCCCGAGGAGGGACGGCATGACAGAGGCGAAAGCGCCCCGCGGCGGAGTCCGGCTACGCGGTGTCACGAAGAGATACGGCCAGGGTGAGGCCCAGCTCAAGGCGCTGGACGGCGTGGACCTGGACATCGAGCCGGGCGAACTGGTGGTCGTGCTCGGGCCCAGCGGCTCCGGCAAGACCACGCTGCTCAATGTGCTCGGCGGCATCGAGCCTGCCGACGAGGGCGAACTGACCGTGGCCGGCGTGGAGCTGACCGGGCGCTCCCCCAAGGACCTGGTGAGCTTCCGGCGGGACCGGGTCGGCTTCGTCTTCCAGTTCTTCAACCTGGTGCCCACGCTCACCGCCCGGGAGAACGTCGAGGCGATGGTGGAGCTGACCGGCCGCGGCGACCGCACGCAGGTGCCCGAACTGCTCGGCTCGGTCAACCTCACCGACCGGATGGACCACTTCCCGGCCCAGCTGTCCGGCGGCCAGCAGCAGCGGGTGTCGATCGCCCGTGCCCTGGCCACCGACCCGGACCTGCTGCTCGCCGACGAACCGACCGGTGCCCTGGACGTGGCCACCGGCAAGTCCGTGCTCCGGCTGCTCCAGGAGACCAACCGGCAGGGCCGCAGCGTGCTGATGGTCACGCACAACGCGTCGGTGGCCTCCATCGCGCACCGCGTGGTGACGATGCGGGACGGCAAGGTCGAGACCGTCGAGCAGAACGCCGCCCCGGCCGATGCCGTCACCGTGAGCTGGTGA	MRPAQEGDPPRRDGMTEAKAPRGGVRLRGVTKRYGQGEAQLKALDGVDLDIEPGELVVVLGPSGSGKTTLLNVLGGIEPADEGELTVAGVELTGRSPKDLVSFRRDRVGFVFQFFNLVPTLTARENVEAMVELTGRGDRTQVPELLGSVNLTDRMDHFPAQLSGGQQQRVSIARALATDPDLLLADEPTGALDVATGKSVLRLLQETNRQGRSVLMVTHNASVASIAHRVVTMRDGKVETVEQNAAPADAVTVSW	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	39.60	gnl|BL_ORD_ID|446|hsp_num:0	487			9	732	erythromycin
BGC0000257.1|Prodigiosin_11 # 11617 # 12339 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.747	BGC0000257.1|Prodigiosin_11 	11617	12339	-	Loose	375	35.8094	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	29.31	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAACGTCAACCCAGGGGCATACCGGAGCCGAGCGGGGAGTGATATGAGTCCGACATCCGCCGAACGCGGTCAGGAGAGCCGGGCGCGGCTGCTCGCCGCGGCGGCCGAGCTGATCGTGGCGGACGGCTGGGGCTCGGTGACCACACGCAAGGTCGCCGACCTGGCCGGCCTGCCGCCCGGCCTGGTCCACTACCACTTCCGTACGGTGACGGACCTACAGATCGACGCCGCGCTGGACGCCGCCCGGCGCGAGGTCGACGCGGCGACGGCGGCGCTGGTCTCGGCCGCCGATCCCGTGGCGGGGATGGCCGAGGTGCTGGATGAGCTGGCCGCCTACGCGGACAACGATCCGGCGACGATTCTCTTCAGCGAGATGCTGCTGGCCGCGACCCGGCACAAGCGGCTCCGCGAGGAGCTGTCGGTCCTGCTGGGCAACTGGCGGTCGACCATGGCCGACTGGCTGCGGTCGCACGGCGGCCCGGCGGACGCCGAGGCGACGGTACTGCTGCTCGGCGCGGCGCTGGACGGCCTGGTGCTGCACCGCATGGTCGACCCGGGGCAGACCCGGGTCTCGGTGGCAGGGCCGCTGCGCCGGCTGGCCGGCCTGCCGCCGCACCAGGGCGCCGGCGCGCAGGGCAGACCCGCAGCGCGGAGCGCGGCACCGCACGGCGCTGCCGGGACGACGACGGACGGACCCTCGGGCGACGGGTCCGTCAGCTGA	VNVNPGAYRSRAGSDMSPTSAERGQESRARLLAAAAELIVADGWGSVTTRKVADLAGLPPGLVHYHFRTVTDLQIDAALDAARREVDAATAALVSAADPVAGMAEVLDELAAYADNDPATILFSEMLLAATRHKRLREELSVLLGNWRSTMADWLRSHGGPADAEATVLLLGAALDGLVLHRMVDPGQTRVSVAGPLRRLAGLPPHQGAGAQGRPAARSAAPHGAAGTTTDGPSGDGSVS	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	111.63	gnl|BL_ORD_ID|2090|hsp_num:0	2306			0	174	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000257.1|Prodigiosin_12 # 13296 # 15173 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.761	BGC0000257.1|Prodigiosin_12 	13296	15173	+	Loose	1000	137.502	almE	26.58	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACCGCCGACGGCGCACAGCTCATCGGACTGCCATCGGACCTGCCTGCCGGGCAGGCGGACCGCCCGGCGCTGCTGGGCGAACGGACCGTCACCTACGGCGAGCTGGCGGCGGACGTGACCGCCACCGCCGCCGCACTGCGCGCGCTCGGGGCCCGCCCCGGCGACCGGGCCGCGATCTGGATGGACAAGCAGCCGCGCTACGCCGAGGCGATTCTCGCCGCGCTGCGCGCAGGCTGTGCGTACGTGCCGCTGGACGGCGGCCAGCCGGCGGCCAGGGCGGCGACGATCCTCGCCGACGCCTCGCCCGTTGTGCTGTTCACCGACGCGCGGCACCTGGCGGCACTCGACGGGCACACCCTGCCGGCGTCGGTGCGCGCGGTGGTGGTGACCGGCGCACCCCGTGACAGCAGCGGGTACGGCGCCCCGGACGGCGCCGAGGTGTGCGCCTGGGCGGACTTCGCCGCCCGCGCGCCGGGCGCCACGGACGCCCCCGCGGCGCAGCCGGACGGTCCGGACGGTGACGCGCTCGCCGCGCTCCTCTACACCTCCGGCTCCACCGGCGTGCCCAAGGGCGTGAAGATCTCGCACCGCAACCTGGCGAACTTCACCGGCTGGGCCCGCACCGAGCTGGACGTGGGCCCGGACGACGTGTTCGCCAACCACGCCTCCTTCAACTTCGACCTGAGCACCTTCGACCTGTTCACCGCGCTCGGCGCCGGCGCGGCCGTCTGGATCATCGACGAGCCGCGGGCCCGTGATGCCTCCGAACTGGCCGCCGGCATCGTCCGGCACGGCGTCACCGTCTGGTACTCGGTGCCCTCCGTGCTCAATCTGCTCACCGTCTCCGGCGCGCTGACCCCGGAGCGGGCGGCCGGGCTGCGGTACGTGCTGTTCGCGGGCGAGGTGTACCCGATGCCGCAGCTGCGCGCCCTGGCCGCCCTGCTGCCCGAACACACCGTGCTGTACAACCTGTACGGCCCCACCGAGACCAACGTCTGCACGTTCCACCGGGTGGGCACCGCGGACCTGGCCCGCGACGAGCCGGCCCCCATCGGCCTGCCCATCAGCAACACCCGGGTCTCGGTGGTGGACGAGGCGGGCCGCGCGGTCACCGGGGCAGGCGCGGTCGGCGAACTCGTGGTGGAGGGCGACTGCGTGACCCCCGGTTACTGGGGCCGCGAGTCGGAACCGGCCGCCGCGGGGCACCGCGCCCGCCGGCACGCCACCGGCGACCTGGTCACCCGCGAGGACGGCAGGCTGGTCTACCGCGGCCGCATCGACCGGATGGTGAAGCTCTCCGGCTACCGGATCGAGCTCGGCGAGATCGAGGCCGCCGTGCTGCGGCACCCCGCGGTCGCGGACGCGGCGGTGGTCGTCGCGGACGCACCCGGCGGGCAGGCCGGGCAGGTGGGGCAGGCCGGGCAGCAGGGGAACCGGGAGACACAGCGGCGGCTCGCGCTGTACTACACGCTGCGCGAGGGCGCCGCGAAACCGACCCTGGTGCAGCTGAAGCAGCACTGCGCCCGGCACCTGCCCGGGTACATGCTGCCGCAGATGGCCACGGTGCTGGGACGCGCTGCCGCGCAACGCCAACGGCAAGACGGACTACGCCCGGCTCACGGAGGCCGGCGCAAGACCGGCCGCGCGCCCGCGCGCCCGTACGCAGCGCACCGGCGGCGGTACCGCGGAGGCGGCGCCGACGGCGCCGGCCGCGGCGCCCGCGGGGACAGCAGCAGCGGACCGGACCCGCCCCCGCGTACCGGCGGAAGGGCCTGCGGCGCAAGGCGCGCCCGGGCGCGGCGGCGGAGACCCTGGTCGACGTGCTGCGCCGGCACGCGGGACACCGCCCGGACGCCCTCGCCTACCGCTTCCTGA	MTADGAQLIGLPSDLPAGQADRPALLGERTVTYGELAADVTATAAALRALGARPGDRAAIWMDKQPRYAEAILAALRAGCAYVPLDGGQPAARAATILADASPVVLFTDARHLAALDGHTLPASVRAVVVTGAPRDSSGYGAPDGAEVCAWADFAARAPGATDAPAAQPDGPDGDALAALLYTSGSTGVPKGVKISHRNLANFTGWARTELDVGPDDVFANHASFNFDLSTFDLFTALGAGAAVWIIDEPRARDASELAAGIVRHGVTVWYSVPSVLNLLTVSGALTPERAAGLRYVLFAGEVYPMPQLRALAALLPEHTVLYNLYGPTETNVCTFHRVGTADLARDEPAPIGLPISNTRVSVVDEAGRAVTGAGAVGELVVEGDCVTPGYWGRESEPAAAGHRARRHATGDLVTREDGRLVYRGRIDRMVKLSGYRIELGEIEAAVLRHPAVADAAVVVADAPGGQAGQVGQAGQQGNRETQRRLALYYTLREGAAKPTLVQLKQHCARHLPGYMLPQMATVLGRAAAQRQRQDGLRPAHGGRRKTGRAPARPYAAHRRRYRGGGADGAGRGARGDSSSGPDPPPRTGGRACGARRARARRRRPWSTCCAGTRDTARTPSPTAS	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	112.41	gnl|BL_ORD_ID|4935|hsp_num:0	5928			102	1593	colistin A; colistin B
BGC0000257.1|Prodigiosin_13 # 15119 # 22489 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=CGGA;rbs_spacer=13bp;gc_cont=0.761	BGC0000257.1|Prodigiosin_13 	15119	22489	+	Loose	750	84.3445	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	31.68	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGCTGCGCCGGCACGCGGGACACCGCCCGGACGCCCTCGCCTACCGCTTCCTGACCGGCGACGCCGGTGAGCCCCCGCAGTCCTGGACGTACGCCGACCTGGACGCCCGCGCCCGCACCATCGCCGCGCGCCTCCAGGAGGACGGCGTCCGTGACGTGCCGGTGCTGCTGCTGCACCCGCCGGGCCTGGAGTACGTCGCCGCCTTCCTCGGCTGCCAGTACGCCGGGGCCATCGCGGTGCCCGCGTACCCGCCGGACGCCGGGCGGTTCGGCCAGACCGTGCCCCGGCTCGCCGCCATCGCCAGGGACACCAGGGCCACCCACGCGCTCACCACGGACGCCTTCCGCCGGATCACCGGGGAGCGGCAGCAGGAGCTGACCGCGCTGGGCCTGGGCGGCCTGACCTGGGTGGCCACCGACGCGCTGGACGGTGCCCGCGCCGACACCTGGCGGCACCCGGGCACCGGCGGTGACGCGGTCGCCTTCCTCCAGTACACCTCGGGCTCCACCGCCACCCCCAAGGGCGTGATCGTCGGCAGCGACAACCTGCTGGCCAACCTGCGCTCCATCCACAGCTACCTGGAGCACGACGAGCAGTCGCAGCTGGTGTCCTGGCTGCCCCCGTACCACGACATGGGCCTGATCGGCGGCATCCTGGAGCCGCTGTACGGCGGCTACCCGTCGCACCTGATGGCGCCCATGACCTTCCTGCGCAGCCCCCGGCTGTGGCTCGCGACGCTGTCCGAGACCGGTGCCTGCACCAGTGTGGCGCCGAACTTCGGCTTCGAGCACTGCATCCGCCGGATCCGCCCCGAGCAGCGGGAGGGCCTCGACCTGCGGCACTGGCGGCTGGCGCTGGACGGCGCCGAGCCGGTGCGCGGTGACACGCTGGAGCGGTTCGCCGAGCTGTTCGCGCCGGCCGGGTTCGACGCCCGTGCCCTGATGCCCTGCTACGGGCTGGCCGAGGCGACGCTGATGGTCACCGGCATCGGGCCGCGCGAGCGGTTCCGCACCACGGCCTTCGACTCCGGGTCGCTGGAGGCGGGTGTTCCGGTGCCCGCGGGGCCCGGCACCCGGCGGACCACGGACGTCGTCAGCTGCGGCGTGCCCATCCCGGACGTGGAGGTGGCCGTGGTCGACCCGGCCACCGGGCGGCGCACGGAGCCGGGCGGCGTCGGGGAGATCTGGATCGCGGGCCCGAACGTCGCGCGGGGCTACTGGGGGCGCACCGACGCCACCGAGGAGTCCTTCCGCGCGGTGATCGAGGGCGAGCCGGAGCGCGCCTGGATGTGCAGCGGTGACCTCGGCTTCGTACGGGACGGTGAGCTGTCCGTGGTCGGCCGGATCAAGGACGTCATCGTCCTGGAGGGCCGCAACCACCACCCGCACGACATCGAACTGACCGTGGAACGCGCCTGCGAGGTGCCGCGCGCGGGCGGCGCCGTCGCGTTCGGCTCCCAGGTGGGCGGCGTGGAACGGCTGATGGTCGGCTTCGAGGTGGATCCGCGGCAGGTGCCTGACCCGGCGCGGCTGCTGGCCACGCTGCGGGCGGCGGTGGCCGCCGAGCACGAGGCATCGCCGCACACCGTGGCGCTGCTGCGGAAGGGTTCGCTGTCCAAGACGACCAGCGGGAAGATCCAGCGGCGGGCGTGCCGGGCGGCGTTCGAGAGCTTCGAGCTGACGGTGCTGGCCGCCAGCGTGTCCCGCGACCTGGACCCCGGCGGGGGCGCGGCGCAGGACGCGCCGCCGCAGCTGTCCGCGGCGGAGCGCCGGGCGCGGGCACTCGCCGCGGTCGGCGAGGCGCTGCGCGCGGCCGGGGCGGCGGACGGCGGCGGCAGCAGCGAAGACGGCGCGTCCGGCGGCCGTACGTTCGCGGATCTGGGCCTCGGCTATCCGGCGGTCACCGCCTGTGCGGCGGACGTCGAACGGCGCCTGGGCGTGCGGATCCCGGTCGGTGAGCTGCTGGTACGGCCCCGGGTGGACACGCTTGTCGCGCTCTGCCTCGGCGAGCGCCCGGGCCAGGACGCGGGCCAGGACGCGGAGCCCGCCCCCGCGGCGGCCGGCGCGGGCGGCACCGGAGCCGCCCCCGGAGCCGCCCCCGAGTCCGGCGACACGTCCGGCGCGTCCGCGCCGCGGCGTCCGCAGCCCGATGCCCGGGAGATCGAGGCGTGGCTGGTCGGACGTGTCGCCCACTGCCTCGGCCTGCCCGAGGAGACCATCGACACCCGGCAGCCGTTCGCGGCCATCGGGCTGGACTCCAAGCAGGCCACCGCGATCGCCGACGAGCTGGGCCGCTGGCTGGACCGCGCCGTCACGCCCGGCCTGGTCTTCGACCATCCGACCGTCGAGCGGATGGCCGCGCACCTGAGCGCCGGCGCCCCGCGCGCCGCCGCCACGCGGGACCGCGCCCCTGAGCGCGCGCCCGCACCCGCGGGCGCCCCGGCGGATCCGGCCGGGGTGCAGGATCCCATCGCCATCGTCGGCATGGCCTGCCGGTTCCCCGGCGCCCCCGACGTGCCGAGCTTCTGGCGGCTGCTCACCGACGCCCGCGACGCCGTCGGCGAGGTGCCCGCGGACCGCTGGGACGCGCGCGCGGTGGACGCCCCCGGGTACGGCGGATTCATCGACGACGTCGGCGAGTTCGACCCGCGGTTCTTCGGCCTGTCCGCGCGCGAGGCGGAACGCATGGACCCGCAGCAGCGGCTGCTCCTCGAACTGGGCTGGCAGGCGTTCGAGGACGCCGGGACCGCCCCCGGCTCGCTGGCCGGCAGCGACACCGGCGTGTTCGTCGGCATCAGCAGCAGCGACTACGCGGAATTCCAGATGCGGCGGCTGGACACCGTCGACGTCTACGGCGCCACGGGCAACGCGCACGCCATCGCCGCGAACCGGCTGTCCTACTTCCTCGACCTGGCCGGGCCCAGCCTGGCCCTCGACACCGCCTGCTCCTCGTCACTGGCCGCGGTGCACGCCGCCTGTCAGAGCCTGCGCGCCGGTGAGTGCACCAGCGCGCTGGCGGGCGGCGTCAACCTGATGCTCACACCGGGCCTCTCGGTGGCCTTCGCGGCCGGCCGGATGCTGGCGCGGGACGGCCGCTGCCGGGTGTTCGACGATGCCGCGGACGGCTATGTACGCGGCGAGGGCGCCGGGCTGGTCTGCCTCAAGCCGCTGTCGGCGGCGCTGGCGGACGGCGACCGGGTATACGCCGTGATCCGCGGCTCGGGCCTGGGCCACGGCGGCCGCAGCAACGGACTGACCGCACCCCGCGGCTCCGCCCAGCGCGCGGTCATCGAGCGCGCGCTGCGCACCTCCGGACTGCGCCCCGACCAGATCGGGTACGTGGAGGCACACGGCACCGGCACCCCGCTCGGCGACCCCGTGGAGTGGGAGGCGCTGGCCGAGGTGTACGGGCAGCGGGCCAGGGGCAAGGAACCCTGCCTGGTCGGCTCGGTGAAGAGCAACATCGGGCACCTGGAGGCGGCGGCCGGCATCGCCGGGCTGATCAAGACCGCGCTGGTGCTGCACCACGGGCACGTGCCGCCGCAGCTCCACCTCAGCACGCGCAACCGGCGGATCTCCTTCGAGGGTTCGGGCCTGACCGTGGCCACGGCCGCCCGCGAGCTGCCGCGCGACGCCGGCGCGCCGGCGCGTGCCGGGGTCAGCTCGTTCGGCTTCGGCGGACAGAACGCGCATCTGGTGCTGGAGGCCGGCACCGGGCCGGGCCCGGACACCACGGACGCGGACGCCGCGCAGGACGCCGCGCAGGGCACCGGTGCCGCCGCGGGCCCGCAGCCGCACGCGCTGTGCCTGTCGGGCCACACGGCCACCGCGCTGGCCACCCTCGCCCGCCGCTACCGCACCCACCTGGCCGCGCACCCCGGCGTGCCGCTGGGCGAGCTGTGCCGCACCGCGAACACCGGGCGCACGCACCTGGCGCACCGGGCCGTGCTCACCGCGGATTCCACCGAGGCGCTGGACGGCGCCCTGGAGCGGCTGGCGCAGGGCGGCGCGTCGCCCGGCATCGCGCGGGGCGACCTCAGCGGGGGCACGGCGGCGCCGCGCACGGCGTTCCTGTTCTCCGGGCAGGGCAGCCAGTACCCCGGCATGGCGCGGGCGCTGTACCGCACGCGGCCGGTGTTCGCGCGTGCCCTGGACGAGTGCGACGAGGTGCTGCGCCCGCTGCTGGACGTCTCGCTGCCCGCGCTGCTGTTCGACGAGGACGGCTCGGGGGACGGTTCCGCGGGCGGCGGCCGGCTCGCCCGTACCCGCTACTGCCAGCCCGCGCTGGTGGCGCTGGAGATCTCGCTCGCGCGGCTGTGGCAGTCGCTCGGCGTGCGCCCGGCGGCCGTGCTGGGGCACAGCGTGGGCGCGCTGTCCGCCGCCTGCGTCGCCGGAGTGCTGTCCACCGAGGACGCGCTGACGCTCGCGGCGGCCCGCGGGCGGTACATGGACGAGCAGCCGGGCGACGGCGCCATGATCGCCTGCATCGGTGACCAGGACCGGATCAGGGCCGTCGCCGGTCGGTACGCCTCGGTCGGCATCGCCGCGGTCAACACCCCCGAGCACCTGGTGCTGTCCGGCGCGGCGGGCGAGATCCGCGGCGCGGGCGGGGAACTGGCCGGGCACGGGGTCACGGTGCGTCCGCTCCGGGTCTCGCACGCCTTCCACTCCACGCTGATGAGCGGTGCCGCCGCCCCGCTGCGGGACGCCGCGCTGCGGCTGCGGCACGGCACGCCCGCCGTGCCCTGGGTGTCCGACGCCACCGGCGAGGTGGTGGACACCGTGGACGCCGGCTTCTGGGCCGAGCACCTGCTCGGCACGGTGCGCTTCGCGGACGGCTTCGCCACGCTGCGCGGCCTGGGCTGCGACGCGTTCGTGGAGATCGGCCCGCACCCGACCCTGATCGACCTCGGCCGCGCCATGCTCGGCGCGGGTCCGCCCGGCGAGCTGGGCCGCACCCTGCTGCTGCCCTCGCTGCGGCGCGGCGACGACACCGGGGAGCCGCTGCTGCGGTCGCTCGGGCGGCTGCACTGCGCGGGCGCCCCGGTCGACTGGGCGGCGCTTGAGCCGGGGCCGCGGCGGGCGGGCGCGCCCGCGCCGCACACGGTCTTCGAGCGGCAGCGGTACTGGATGACGCCCCCTGACCCGGCGGCGCCCGCGGTGCCGGGGCCCGCCCCCGCCCGTGCCGCCGCCCATGCCCATGCCAACGGCCAGGCCGCTCACCCGGGCGCCAGGCCGGTCACCAGCCACAGCAACGGAGGCCCGGTGCAGCCGAACGGACAGCCGAACGGACATCCGAGCGGTGGGGCGTCCGCCCCGTACGGCGCGGCCAACGGAACGCCCGGCGCGGGCACCGCCCAGCACACCGCCGCCCAGCACACCGCCGCCCAGCTCACCGCCACTCAGCTCACCGCGCACGCCGCCACCCACCAGGGCAACGGTGCCGTGAGCCAGGCACGGCCCGCGCCGGGCGTGCTCGGCGCCTCGGCGGCCCTGGACCACGCGCCCGGCGGGGCGCCGTACCCGCTGCCCCGGGTGCCGGGTGTGCCGGGCATGCCCGCGCCGTACGGTGCGCAGCCGGCGCCGCAGCACGCCCCCGCGCCGCACGCCGCCCCGGAACCGGCGGCCGGCGCCCAGCAGTTCGTGCTCAGCCAGATCGCGCAGATCACCGGGTTCCCGGCGCACGAACTGGCCGTGCACGCCCGGCTCGGCGCGGACCTCGGGTTCGACTCGCTGATGCGCAGCGAGCTGGAGCGCCGGATCGCCCAGCAGTACCCGGGGCAGCTGGAGGAGCTGCGCCGGGGCCTGCCGGAGGACCCGGCGGTGGAGCAGATCCTCGGGGTGCTCACGTCGGCGCCCGCCGCGCAGGGCGCGCCGCAGCCGGCGGGCCACCCGCAGCCGCCGCACCAGCCGGCCGCACAGCCGCAGCCGTACCCGCAGCCGCAGCCGTACCCGTACCTGTATGCCGGCGCGCCGGTGCCCATGGCCGCGCACCCCGGATACCCGGGATACCCCGCCTACATGATGTACCCCGGGCACCCCGGGTACGCGCCCGCGTACGCCCCGGGAGCCCCGCACGCCCCGCAGTTCGCCGCCCCGCCGCCCCCGGCGCAGTCCGTACCGGCCGCGCCCGCCGCCCCGCCGGACGGTGCCGACGGCGCGCAGAACGGCGCGGCGGTGGTCCCCGAGCGCTCCTTCGAGGAGTCCGCCGAGTACCTGGAGCTCCAGGAGCGCCGCCGCCGGGCCACGGCCGGCGGGCTGAACCCGTACGGCCGGCTGCACGACGGCCACAACGCCGCCGCCGCCGAGATGGCGGGCCGCAGGCTGCTGAACTTCGCCGCGTTCAACTTCCTCGGCCTCTCCCACCACCCCCGGGTGATCCAGGCCGCGAAGGACGCCGTCGACCGGTACGGCACCTCCGCCTCCGCCACCCCGGTGCTGTTCGGCGAGACACCGCTGCACCATGAACTGGAGGACGAGCTCGCCTCCTTCCTCGGCACCGAAGGCGCGATCGTCTTCCCCGGCGGCCACGCGACCAACGTCGCCACCGTCGGCCATCTGCTCGGCCCGCAGGACCTGGTGCTGCACGACGAGTGGATCCACGACAGCACCGTGCGCGGCGCGGTCCTCTCCGGCGCGCGCCGCCGCCCGTTCCCGCACAACGACTTCCGCGCCCTTGAGCGCCTCCTGGAGCGGCTGCGCGGCCAGCACCGGCGGGTACTGATCGTGATCGAGGGCGTCTACAGCCAGGACGGCGACCTGCCGGACCTGCCCGCGTTCATCGACGTGAAGAAGCGCCACGACGCCCTGCTGATGATCGACGAGGCGCATTCGATCGGCGTGCTCGGCGGCACGGGCCGCGGCATCGGCGAGTACTACGGCACCGACCGCGGCGACGTCGACCTGTGGATGGGCACCCTGAGCAAGGCGCTCGGCAGCCTCGGCGGCTACGTCGCGGCCCGCCGCAGCCTGATCGACTACCTCAAGTACACGACGCCGCTCTACATCTTCAGCACCGGCATCTCGCCCGGCAACGCGGGCGCCGCCCTGGAGGCCGTCCGGGTGCTGCGGGAGGAGCCGGAGCGCGTCACCCGGGTGCGGGAGCTGGCCGAGTACTTCCGTGACCTGACTGCCCGTGCCAGGGGCCTGGACACCGGCGTGTCCCGCGAGTCGGCCATCATCCCCGTCCTCATCGGGGACTGGCAGCGGGCCATGGAGGTCTCCAACCGGCTGCTGGAACAGGGCGTCAACGTGATGCCGATCGGCTATCCGGCCGTCGCCCGCGACCAGTCCAGACTGCGCTTCTTCATCAACACCGACCACCGTGAATCCGACCTCGACCACGCACTCGACCTGCTGGGGCGGCCATGA	MLRRHAGHRPDALAYRFLTGDAGEPPQSWTYADLDARARTIAARLQEDGVRDVPVLLLHPPGLEYVAAFLGCQYAGAIAVPAYPPDAGRFGQTVPRLAAIARDTRATHALTTDAFRRITGERQQELTALGLGGLTWVATDALDGARADTWRHPGTGGDAVAFLQYTSGSTATPKGVIVGSDNLLANLRSIHSYLEHDEQSQLVSWLPPYHDMGLIGGILEPLYGGYPSHLMAPMTFLRSPRLWLATLSETGACTSVAPNFGFEHCIRRIRPEQREGLDLRHWRLALDGAEPVRGDTLERFAELFAPAGFDARALMPCYGLAEATLMVTGIGPRERFRTTAFDSGSLEAGVPVPAGPGTRRTTDVVSCGVPIPDVEVAVVDPATGRRTEPGGVGEIWIAGPNVARGYWGRTDATEESFRAVIEGEPERAWMCSGDLGFVRDGELSVVGRIKDVIVLEGRNHHPHDIELTVERACEVPRAGGAVAFGSQVGGVERLMVGFEVDPRQVPDPARLLATLRAAVAAEHEASPHTVALLRKGSLSKTTSGKIQRRACRAAFESFELTVLAASVSRDLDPGGGAAQDAPPQLSAAERRARALAAVGEALRAAGAADGGGSSEDGASGGRTFADLGLGYPAVTACAADVERRLGVRIPVGELLVRPRVDTLVALCLGERPGQDAGQDAEPAPAAAGAGGTGAAPGAAPESGDTSGASAPRRPQPDAREIEAWLVGRVAHCLGLPEETIDTRQPFAAIGLDSKQATAIADELGRWLDRAVTPGLVFDHPTVERMAAHLSAGAPRAAATRDRAPERAPAPAGAPADPAGVQDPIAIVGMACRFPGAPDVPSFWRLLTDARDAVGEVPADRWDARAVDAPGYGGFIDDVGEFDPRFFGLSAREAERMDPQQRLLLELGWQAFEDAGTAPGSLAGSDTGVFVGISSSDYAEFQMRRLDTVDVYGATGNAHAIAANRLSYFLDLAGPSLALDTACSSSLAAVHAACQSLRAGECTSALAGGVNLMLTPGLSVAFAAGRMLARDGRCRVFDDAADGYVRGEGAGLVCLKPLSAALADGDRVYAVIRGSGLGHGGRSNGLTAPRGSAQRAVIERALRTSGLRPDQIGYVEAHGTGTPLGDPVEWEALAEVYGQRARGKEPCLVGSVKSNIGHLEAAAGIAGLIKTALVLHHGHVPPQLHLSTRNRRISFEGSGLTVATAARELPRDAGAPARAGVSSFGFGGQNAHLVLEAGTGPGPDTTDADAAQDAAQGTGAAAGPQPHALCLSGHTATALATLARRYRTHLAAHPGVPLGELCRTANTGRTHLAHRAVLTADSTEALDGALERLAQGGASPGIARGDLSGGTAAPRTAFLFSGQGSQYPGMARALYRTRPVFARALDECDEVLRPLLDVSLPALLFDEDGSGDGSAGGGRLARTRYCQPALVALEISLARLWQSLGVRPAAVLGHSVGALSAACVAGVLSTEDALTLAAARGRYMDEQPGDGAMIACIGDQDRIRAVAGRYASVGIAAVNTPEHLVLSGAAGEIRGAGGELAGHGVTVRPLRVSHAFHSTLMSGAAAPLRDAALRLRHGTPAVPWVSDATGEVVDTVDAGFWAEHLLGTVRFADGFATLRGLGCDAFVEIGPHPTLIDLGRAMLGAGPPGELGRTLLLPSLRRGDDTGEPLLRSLGRLHCAGAPVDWAALEPGPRRAGAPAPHTVFERQRYWMTPPDPAAPAVPGPAPARAAAHAHANGQAAHPGARPVTSHSNGGPVQPNGQPNGHPSGGASAPYGAANGTPGAGTAQHTAAQHTAAQLTATQLTAHAATHQGNGAVSQARPAPGVLGASAALDHAPGGAPYPLPRVPGVPGMPAPYGAQPAPQHAPAPHAAPEPAAGAQQFVLSQIAQITGFPAHELAVHARLGADLGFDSLMRSELERRIAQQYPGQLEELRRGLPEDPAVEQILGVLTSAPAAQGAPQPAGHPQPPHQPAAQPQPYPQPQPYPYLYAGAPVPMAAHPGYPGYPAYMMYPGHPGYAPAYAPGAPHAPQFAAPPPPAQSVPAAPAAPPDGADGAQNGAAVVPERSFEESAEYLELQERRRRATAGGLNPYGRLHDGHNAAAAEMAGRRLLNFAAFNFLGLSHHPRVIQAAKDAVDRYGTSASATPVLFGETPLHHELEDELASFLGTEGAIVFPGGHATNVATVGHLLGPQDLVLHDEWIHDSTVRGAVLSGARRRPFPHNDFRALERLLERLRGQHRRVLIVIEGVYSQDGDLPDLPAFIDVKKRHDALLMIDEAHSIGVLGGTGRGIGEYYGTDRGDVDLWMGTLSKALGSLGGYVAARRSLIDYLKYTTPLYIFSTGISPGNAGAALEAVRVLREEPERVTRVRELAEYFRDLTARARGLDTGVSRESAIIPVLIGDWQRAMEVSNRLLEQGVNVMPIGYPAVARDQSRLRFFINTDHRESDLDHALDLLGRP	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	590.38	gnl|BL_ORD_ID|1968|hsp_num:0	1943			504	1239	isoniazid
BGC0000257.1|Prodigiosin_14 # 22486 # 23610 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=ACC;rbs_spacer=13bp;gc_cont=0.743	BGC0000257.1|Prodigiosin_14 	22486	23610	+	Loose	1200	35.8094	arnA	26.29	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACTGACAGCGTGACCGAAGCGACCGGGCCCGCCGCGGAGCCGGCCCCCGAGGTGCTGGTGCTGGGCGCCACCGGCTTCATCGGCGGCCATCTGACCAGGCGGCTGGCCGAGTCGGGGCGCCGGGTACGGGTGCTGGCCAGGCCGGGCAGCGACCGGAGCGGGCTGGAGGGGCTGCCGGTCGAGACCGTCACCGGCTCGCTCGACGACCTGGACAGCCTGCGCCGGGCCGCGCGCGGGGTGCGCCACGTGTACAACTGCGCCGGCCTGTCCGCCGACTGGGGCAGCTGGGACAGCTTCCGCAAGGTGAACGTGGACGGCGCCAGGAACGCCGTGCTGGCCTGCGAGCACGCGGGCACCGTCGAGCGGCTGCTGCACGTGAGCACCACCGATGTGTACGGCTACCCCGCACTGCCCTGCGACGAGAGCGCCGGCGTCCAGGACATCGGGCTGCCCTACAACCGCAGCAAGCTCCGCGGCGAGGCCGCCGTGCGCCAGGCGGCCAAGCGCGCCGGGCTGCCGTACACCATCGTCCGGCCGGTCTCGGTGTACGGGCCGCGGTCCAAGGACTTCGTCATCGAGATCGGCCAGCTGCTGGTGCGCAAGCAGATGGTGCACATCAGCGGCGGCGCCGCCCCGGCGGGCCTGCTGTACGTGACGAACGCCGCCGACGCCATGATCGCCGCCTGCGAGAGCGACCGCACCGCGGGCAAGGCGTACAACCTGCGCGACGAGGGGATGACCACCTGGCGCGAGTACGTGGACGCCCTCGCCGCCGGGCTGGGCGTGAAGTCGCCCTCGATGAGCCTTTCCAGGCCGGTCGCGATGACCGTCGCGCGGCTCTCCGAGGCGGTGTACGGGGCGCTGCGGCTCAGCTCCCGCCCGGTGCTCACCCGGCACGCCGTGAACCTGTTCGACCGCGACCAGTCCTACGGCATCGCGCGTGCCCAGGAGGACTTCGGCTTCACCAGCACCGTCGGCTTCGAGGAAGGCATGCGGCGCACCCTGGAGTGGCTGGACTCGCCCGAGGGGCGGGCCCAGGTCGTCCGGAAGGGCGCCGCCACCGCCGGGGCCGGCGCGCCGCAGCCCGCCGCGCCCGCCGGGCGCGCCGAGGAGGCCGCGTGA	MTDSVTEATGPAAEPAPEVLVLGATGFIGGHLTRRLAESGRRVRVLARPGSDRSGLEGLPVETVTGSLDDLDSLRRAARGVRHVYNCAGLSADWGSWDSFRKVNVDGARNAVLACEHAGTVERLLHVSTTDVYGYPALPCDESAGVQDIGLPYNRSKLRGEAAVRQAAKRAGLPYTIVRPVSVYGPRSKDFVIEIGQLLVRKQMVHISGGAAPAGLLYVTNAADAMIAACESDRTAGKAYNLRDEGMTTWREYVDALAAGLGVKSPSMSLSRPVAMTVARLSEAVYGALRLSSRPVLTRHAVNLFDRDQSYGIARAQEDFGFTSTVGFEEGMRRTLEWLDSPEGRAQVVRKGAATAGAGAPQPAAPAGRAEEAA	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	56.50	gnl|BL_ORD_ID|1513|hsp_num:0	1643			957	1494	polymyxin B
BGC0000257.1|Prodigiosin_16 # 24976 # 26304 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=CGGA;rbs_spacer=13bp;gc_cont=0.701	BGC0000257.1|Prodigiosin_16 	24976	26304	+	Loose	710	28.8758	efrB	35.56	3003949	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGATCCCCAACCAGTGGTATCCCGTGGCGCGTTCGAGGGACGTGAAACAGAACAAACCGAAGGGCGCCATGCGCCTGGGCGAAGAAGTGGTGATGTGGCGCGACGCGCGCGGCAACGCCGTCGTGCAGGAGGCCCGCTGCCCGCACAAGGGCGCGAACCTCGGCGCGGGGCGGATCAACCAGAACGCGCTGGAGTGCCCGTACCACGGCTTCCGGTTCGGCGCGGGCGGCGACTGCGAAGCGGTGCCCTGCCTCGGCTCCGAGGCCCGTATCCCCAAGGGCCTGCGCATCCGCAACTACCCGGTGCGGGAAGAGCACGACATGGTCTGGATGTGGTGGGGGGAGGAGCGGGAGAGCTACCCCGAGATCGACATCCCGCCGGAGGTCACCCGCTGGAAAGGCGTGCACGTCACCGGCTCCTGGCAGCAGCCGGTGCACTACACGCGCTACATCGAGAGCATGCTGGAGTTCTACCACGCGCCCTTCGTGCACCGCGGCTCGTGGTTCAACTACCTGGACTACATGTTCCTCTACGGGACGCTCCGCAAGTTCGGCATGGACGGCCGCGCCCGCTACCTCGCCGCCTGCAAGGTCGTCGACCACGAGCTGGAGGTGGACGGCACCACGCTGCGGTCCTCCTTCAACCTCACCCGGGAGGACGACCCCGAGCGCGGCGAACCGTACAAGGTGGTCTTCGCGTTCCCCGGCATGGTCCACGTGATGAACCGCAAGTTCGACATCACCATGTGGCTCACGCCGATCGACGAGAAGAACACCCAGATCCTGTTCCGCTGGTACGAGGCGGAGAAGCTGGCGCCGTTCCTGCGCAGCAGGCTGCTGCGCGGCGCGGTGCCCGGCGGGGCCATGATGCTCCAGCGCTGGGTGCCGGAGCGGCAGGACATGCGCGTCATCCTCGGCCAGGAGCCGATGGCGAGCGAGCGCGGCGAGAACAAGTTCATCGCGGTGGACGAGATGAACGCCCGCTACCTGTCCCTGCGGCACAAGCTCATCCAGCACAACGGTGAGCTGCCGTCCGAAGGGGACCAGGACGCGGCAGGCAGGCCGCAGGAGGGCACCGCGGGCCGCGCACCCCGGCTGAACGGTTCGGGGGCGGTCATCGACCCGGCCGTCAAGGCCGCGATGACCAGGTCCGAGGCGAGGTCCGCGCAGAACGGCATGCCCGGCATGCCCGGCATGCCGAACGGCTCGGCCCGCCCCGGGCCCGCCCAGGGCAGCGGACGCGGCCCTGGCCGGGTGGTTGCCGCCGCGCGCGCCAAGGCGCGGATGGCCGCCGCCGAACGCGCCGAACGGGCGGCCGCCCGGCGCTGA	MIPNQWYPVARSRDVKQNKPKGAMRLGEEVVMWRDARGNAVVQEARCPHKGANLGAGRINQNALECPYHGFRFGAGGDCEAVPCLGSEARIPKGLRIRNYPVREEHDMVWMWWGEERESYPEIDIPPEVTRWKGVHVTGSWQQPVHYTRYIESMLEFYHAPFVHRGSWFNYLDYMFLYGTLRKFGMDGRARYLAACKVVDHELEVDGTTLRSSFNLTREDDPERGEPYKVVFAFPGMVHVMNRKFDITMWLTPIDEKNTQILFRWYEAEKLAPFLRSRLLRGAVPGGAMMLQRWVPERQDMRVILGQEPMASERGENKFIAVDEMNARYLSLRHKLIQHNGELPSEGDQDAAGRPQEGTAGRAPRLNGSGAVIDPAVKAAMTRSEARSAQNGMPGMPGMPNGSARPGPAQGSGRGPGRVVAAARAKARMAAAERAERAAARR	LDTCRIFRRNAKSPVNIAKHAKFIRRLKWLCSENMTGFSVLKLYVRKKKPLKGFKQVNHRFKWFGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQPMGNITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPEKPLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSVFGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHR	122.10	gnl|BL_ORD_ID|2183|hsp_num:0	2422			888	1023	erythromycin; ciprofloxacin; rifampin
BGC0000257.1|Prodigiosin_17 # 26541 # 27416 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=ACC;rbs_spacer=13bp;gc_cont=0.767	BGC0000257.1|Prodigiosin_17 	26541	27416	+	Loose	1900	26.9498	mexN	30.0	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGATCCGGCCGGTGCGGCGGTGTGCGCACGTGGTACGGACGGACGGCGGTCCGCGCCACCTGCCCCGCCGCCCGCTGGTGCGCGAACAGGCCGGGCTGGTGTGGCTCTGGTGGGGCGCGGAGCGGGAGACGTACCCGGAGCCCTGGCTGCCTCCCGAGGTCGGCCGGCGCCCCGGCGTGCACGTGACCAGTTCCTGGGAGCGCCCGGTGTCCCCCCTCCGCTACCAGGCCGGCCTGCTCGACCTGTACCACGCGCCCGACCGGCACCACGGATGGTGGTACAGCCGGCTGGACTACGCCGTGCACGGCACACTGCGCGCCCTGTGGTTCGACGGGCGCGCCCGCTACCTGGCCGGCTGCGAACTGGCGGACCACCGCCTCGATGTGGACGGCGACACGGTGCGCTCCTCGTTCCGGCTCGCCCAGCGGGGCGGAGACCCGGCGCTCGACGAGCGGTTCACGCTGGTCATCACCCCCGGCATGGTGCATGTCCAGAGCCCGCGGCTGGACTTCACGGTGTGGCTGACGCCGGTCGACCACCGCCGTACCCTGCTGTTCTTCCGCTGGTACGAGGTCGCGGCGCTTGCACCGTACCTCAGGTTCCCGCTGCTGCGGGCGGCGCTGCCGGCGCTGATGATGCTCTGTCAGCGGCTGGTGCCGGCGCGGCAGATTGTCCGGATGGCCGCCGGCGCGCCGACGGGGGCCACCGCCGGCCCAGCGCCGGCCTGCCGGCGCCCGGCCGGCCGCACCGCCCCGGCACTCCCGTACGCGGCCTGGCGCGGACGCGCCGGCGCCCGCCGCCCGGCCGCCGGCAGCCCCGGCACCGCCCGCCTCCGGCAGGCCGCCGGCCTGCCGCAGGACAGCCCACGCCTGTGA	MIRPVRRCAHVVRTDGGPRHLPRRPLVREQAGLVWLWWGAERETYPEPWLPPEVGRRPGVHVTSSWERPVSPLRYQAGLLDLYHAPDRHHGWWYSRLDYAVHGTLRALWFDGRARYLAGCELADHRLDVDGDTVRSSFRLAQRGGDPALDERFTLVITPGMVHVQSPRLDFTVWLTPVDHRRTLLFFRWYEVAALAPYLRFPLLRAALPALMMLCQRLVPARQIVRMAAGAPTGATAGPAPACRRPAGRTAPALPYAAWRGRAGARRPAAGSPGTARLRQAAGLPQDSPRL	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	28.09	gnl|BL_ORD_ID|2021|hsp_num:0	2217			1431	1644	chloramphenicol; thiamphenicol
BGC0000257.1|Prodigiosin_18 # 27450 # 28550 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=ACC;rbs_spacer=14bp;gc_cont=0.701	BGC0000257.1|Prodigiosin_18 	27450	28550	+	Loose	500	28.4906	chrB	36.96	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGGTATCCCGTCGCACGGTCCAAGGACGTCCGCAGGAACCGGCCGACCGGTGGCAAGCGGCCTGGCCAATAATGGTGATGTGCCGCGACGCGCGCGGCAACGCCGTCGTGCAGGAGGCCCGCTGCCCGCACAAGGGCGCGAACCTCGGCGCGGGGCGGATCAGCCGGAACGCGCTGGAATGCCCGTACCACGGCTTCCGGTTCGGCGCGGACGGGGACTGCGAAGCGGTGCCTTGCCTCGGCTCCGAGGCCCGTATCCCCAAGGGCCTGCGCATCCGCAACTACCCGGTGCGGGAAGAGAACGACCTGGTCTGGATGTGGTGGGGCGAGGAGCGGGAGAGCTACCCCGGGATCACCGCACCGTGGGAGGCCGCCCGCCACACCGGCGTGCACGCCACCGGCTCCTGGCAGCGCCCGCTGAACTACACGCGCTACATCGAGAGCATGCTGGAGTTCTACCACACGCCCTTCGTGCATAGCCGGGTCGTGGATTCAGCGGCCCCGACTACCTGTTCTACGGCACGCCGGGGAGGCTTTGGCGGGACGGGCGGCAGCCGCTATGTGGAGACCGCGAAGGTGGTCGACCACAAGGTGGAGACGGAAGGGACCACGCTCCGCTCCTCCTTCCGGCTGGTCCGCGAGGAGGACGAGGACGACCCCGCCAAGGGCGAACCGTTCACCATCGTGTTCACGTTCCCCGGCATGGTGCACGTCGTCAACGCGCGCTTCGACTTCACCATGTGGATCACGCCTGTCGACGAGGACCACACGCAGATCCTGTTCCGCTGGTACGAGGCCGCCTGGCTGCGGCCGTTCCTGCCCAGCAGGCTGCTGCGCGGCATCGCGCCGGGGCTGGGCACGGTGCTCCAGCGGATGGGCCCCGAGCCGCAGGACATGCGGGTCATCGCCGACATGCATCCGAAGGTCAGCCGGCGGGGCGCGTACAAGTTCGTCGCGGCCGACGAGATGAACGCCCGCTACCTGACGATCCGGCACCGGCTCCTGCACGGCGATCCGCCGCCGGAGGAGCACGCACCAGCCCAGGCCGGGCCCGGGCGGCAGGCCGGCCGGGCCGCACGAACCCACGTCCGTACCACCTAA	MVSRRTVQGRPQEPADRWQAAWPIMVMCRDARGNAVVQEARCPHKGANLGAGRISRNALECPYHGFRFGADGDCEAVPCLGSEARIPKGLRIRNYPVREENDLVWMWWGEERESYPGITAPWEAARHTGVHATGSWQRPLNYTRYIESMLEFYHTPFVHSRVVDSAAPTTCSTARRGGFGGTGGSRYVETAKVVDHKVETEGTTLRSSFRLVREEDEDDPAKGEPFTIVFTFPGMVHVVNARFDFTMWITPVDEDHTQILFRWYEAAWLRPFLPSRLLRGIAPGLGTVLQRMGPEPQDMRVIADMHPKVSRRGAYKFVAADEMNARYLTIRHRLLHGDPPPEEHAPAQAGPGRQAGRAARTHVRTT	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	130.71	gnl|BL_ORD_ID|274|hsp_num:0	305			6	135	tylosin; chalcomycin; mycinamicin
BGC0000257.1|Prodigiosin_19 # 28562 # 29650 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=ACC;rbs_spacer=14bp;gc_cont=0.716	BGC0000257.1|Prodigiosin_19 	28562	29650	+	Loose	550	32.7278	RlmA(II)	20.57	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGGACACAATGACTCCCCCCGACGGCGTGGCACGCCGCCGGGCGAAGCGGGTGGCCAACGCCGCCGGCGTCGCCAGGATCGCCGCCTCACCGCAGGTACCGCTGCTGCTCATGATGTCCCGGCGGCTCATCACGCCGGTCTACCGGGCCGCCTTCCTGGTGGCCGCGTCCAGCTCGGGGCTGCTGCGCCTGCTGGACCACCGCCCCTGCGACGCCGACTCGCTGGCCGGGAAGATGGAGATCAGGGACGTACGGCTGCTGCGGCTCTGGCTGGACGCCGGCGTCCGCCTCGGCGTGCTCGACCAGCGCTTCGACGGCTGCTACAAGCCGGGCAGCCGGGCCGCCAAGATGCTCGCCAAGGTACGGCACGACGCCGCCGCCGCGGCGCTCGAAGAGGTACTGCGCTACCACGTGCCGGCGCTGCTCAACGCTCCCTCGATGCTCAGGGAGGGGCGGCGGTTCTCGCTCGCCGACCAGGACGGCACGGTCATCGCCCGCTCCACCCAGGTGGTCACGCCGCTCGTGCACGAGGCGATCACGCACAGCGTGCCGCGCACCGGGCCGGTGCGGCTGCTGGAGATCGGCTGCGGCAGTGGAGTGCACGTACGGCACGCCGCCTCGCTGAACCCGCACCTCACGGCGCTGGCCGTGGACCTGCAGGCCGAGGTGGCCAAGCAGTGCGCCGAGAACATCGAGGACTGGGGTCTCGCGGACCGGGTCGAGGTCACCCAGGGCGATCTGCGCACGCTGGACCTGGAACCGCAGTTCGACCTGGTCACGATGCACAACAACATCTACTACTTCGCCGAGGACGAGCGGGTCGAGGCGCTGCGCCGGGCGCGGGAACTGCTCACCCCCGGCGGGCGGCTGCTGGTCACCACGGCCTGCCAGGGCGGACACCTGAGCCTGGACATGCTCAACCTGTGGCTGGAGTGCGCCGACTTCGGCGGGCCGCTGCCCAAGGAGCGGGAGCTGCTGGAGCAGCTGCGGGAGGCGGGGTTCGCCGACGCGAGTGCGGCGAAGATCGTGCCCGGCGAGGAGTTCCGTGCCTTCAGCGGCACGAACACGGACCTGGCGCAGCAGGACTGA	MDTMTPPDGVARRRAKRVANAAGVARIAASPQVPLLLMMSRRLITPVYRAAFLVAASSSGLLRLLDHRPCDADSLAGKMEIRDVRLLRLWLDAGVRLGVLDQRFDGCYKPGSRAAKMLAKVRHDAAAAALEEVLRYHVPALLNAPSMLREGRRFSLADQDGTVIARSTQVVTPLVHEAITHSVPRTGPVRLLEIGCGSGVHVRHAASLNPHLTALAVDLQAEVAKQCAENIEDWGLADRVEVTQGDLRTLDLEPQFDLVTMHNNIYYFAEDERVEALRRARELLTPGGRLLVTTACQGGHLSLDMLNLWLECADFGGPLPKERELLEQLREAGFADASAAKIVPGEEFRAFSGTNTDLAQQD	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	128.37	gnl|BL_ORD_ID|2052|hsp_num:0	2274			75	432	tylosin; mycinamicin
BGC0000257.1|Prodigiosin_20 # 30184 # 33294 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000257.1|Prodigiosin_20 	30184	33294	+	Loose	1500	246.128	rphB	24.79	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	GTGGGACCGGTCGCGCGGAACGCGACGGCCTCGTCCGCGGTGGAGCCGCGGGAGGTGGCCGGGGCCGGGGATGATGCCGCCCGTCAGGGCGGGAAGGCGGCACGGTCGCGGGCGAAGAAGGCGGCGGGCGGTGACCCGTCGCGCAAGGCACCCGCCGCGAAGGCGGCCAGGCGGAAGACGGCCGCACCGTCCCGCCGTTCCCCCGCCGGCACCAGCCCGGCGGCGGAGCCGCCGGAGCCCGCCGCCGCTGCGGCGGGAACGCGCGCCCCCGCGCCGCCCGCGGATGGCCATGGTCCGCCCACCGGGCCCGGCACGGCGGCGGAGCCGCCCGCCCGCGCCCGGGCCGGCGCGTCCGCCGCGGCGCCGGAGGCGCCGTCGGCGGACGTCGCCGTGCTCGGCGCCGACGCCGCGGCGAAGCCGGAAACGCTGGGGGGCAAGGCCGCCCGTCTCGGCGAGATGATCGAAGCCGGCTTCCCCGTGCCGCCCGCCGTCTGCCTGACCACCGAGCTGTTCCACCGCTTCCTGCGCGAGACCGGCCTGGACAAGGAGATCGCGGGCGCGGACCGCCGCACCATCCGCGAGCTCGTCACCGGGCGGGAGATCCCCGCCGGTATCGCCTCGGTGATCACCGGCGCCTACCGCGGGCTCGGCCGCCCCTGCGTGGCCGTCCGGTCCTCGGCCGGCAGGAGGACTCGGCCGCGCAGTCGTTCGCCGGGCAGCACGACACGCTGCTCACTGACCGGCGACGACGCCGTGCTGGACGCCGTGCGTTCCTGCTGGGCCTCGCTGTGGTCGGACCGGGCCGGCGTGTACCACGACAGCGACGGCGACAACGACGGCGACAGCGACGGCGAAGGTGACGGCGACAGCACCGGCAGTACCGGCGCCGGTTCCATGGCCGTCGTCATCCAGGAGATGGTGCAGGCCGAGGTCAGCGGCGTGCTCTTCACCGTGGACCCGGTCAGCGGCCGGGAGCACCGCCTGGTCGTCGAGGCGTGCCGTGGCCTGGGCGAGGGCCTGGTCTCCGGGCGGGTGTCCAGCGACTTCTTCGCCCTGGACGACCGTACGTTCGAGGTGACCGAGCGGCTGATCCGGTACAAGGTGATGAAGTGCGCCCCGGTGGCGCCCGGTCAGGTCGGCATGGAGAAGGTGGACGCCGCCGCCCGCAACGCGCCCTGCCTCACGGGCGGCGAGCTGCGCGAGCTCGCCCAGCTCGCGGTGCGGGTCCGCGAGCACTACGGCGCCGAACAGGACATCGAATGGGCGCTGCGCGACGGCGAACTGCTGCTGTTGCAGACCCGCCCGATCACCACCGTGTCCGCCGGCGCGCCGCCGCCCGCCGCGGCGGGGGCGCGCAGCCCGTACGTCGAGGAGCAGCCGGAGGACATCCAGCAGGGCACCATGTGGTCCCGGATGGACATCGGCGAAATCTTCGTCGGCCTGATGACGCCGCTCGGCCTGTCCTGGGCCCGGCACCACCAGAGGTATGTGCACGGCCCGTGCGCTGCTTCGGTGGGCGCCAGGGACATGGGCGACCCCACCCGCTACATGGGCTACCTCCAGGGGCACGACAACCAGAACGTGTCGTACCACGCCCATCTGCTGGGGCAGTGCCCGCCCACCAAGAACCAGGAGCACTTCACCCGCCGTTTCGTCAGCGAGGAGGTGGACCTCGACCAGTACCGGAACCCGTTCGGCGCCTACCCGAAGGGCCTCAAGGGGCTGCGGTCGGCGAACTTCTGGGCCCGCACCACGGTCGCCGAGATGCGCGGCATGGCTGCGCGGGCACAGCACATGGCGACGGCCAGACTCTACGAGTTCGACCGGTCGCGGGCCCTTGACCTGTCGCTGTTCGACCGGCGCGAGCTGCATGTGGAGCTGGGCAGGTACCTGGTCAACTACCACGACATGCACGTCGGTTACATGCCGTACTACATCAACGCCTTCGGCGCGTACGGGCTGATGACCGAGCTGTGCGCCAAGTGGCTGGGCGACGCGGGCGCCAACCTCCAGAACCGGCTGAAGATGGACATGTCCAGCCTGCGCACCGTCGCCTCGGCCCAGGACATCTGGGAGCTGACCCAGGCCGCGCAGGCGCGTCCCGAGGTGCTGCGCCTCATCCGGGAGACGCCGCTGGAGAAGGTGGCGGACGCGCTGCTCGCCGATGTGGCGGGGCAGGAGTTCTGGGAGGGGCACCTGGAGCCGTTCCTGCGGGAGAACGGCGTGCGCGGCCGGCAGGAGATGGAGCTCACCAACCCGCGCTGGGTGGACGACCCGGCGTACGTGTTCCAGATGATCCGCCGGTACGCGGACGACAGCACCGCGGTCCAGGAGATCCTGGCCAGGGACCGCACCACGACCGGCGAGGACATCGAGGAGGTGCTGGCGCGGCTGCCGCGCATGAAGCGGGCGACGCTGCGCAAGGTGATCGGCCTGTACATCGGCAACAGCACGCTGCGCGAGGTCGCCAGGATGGCGATGGTCACCTCCATCTGGCAGGTGCGCAACATCGTGTACGAGGTGGCGCGCCGGCTGACCGAGGAGGGGCTGCTGCACTCGGTGGACGAGGTGGCGTACCTGGAGTTCCAGGACATCCAGCGCTACCTGGCCGGGGACGAGCCGGCCAGGGACATCTTCACCCGGGAGCGGATCGACGAGGCGCAGCGCCTGCACGACTACAACAACCGGCTGCCCGAGCCGCCGCTCACCTTCATGGGGGAGCACGACGCCACCCGCGCGTTGCAGGCGGCGGTGGCGGAGGCGGGCACGGGCCTGACGGGCCTCGGGTCGAGTCCGGGCCGGATCACCGGGCGGGCACGGATCATCGAGGACCTGGTGTGGCAGGCCGACGAGTTCCAGGTCGGCGAAATCCTGGTGACCCGGTACACGGACGCGTCGTGGACGCCGCTGTTCGCGATCGCCGGCGGGGTGGTCACGGACATCGGCTCGATGCTCTCGCACAGCTCGATCGTGTCGCGTGAGTTCAACGTGCCGTCCGTGGTCAACACCAAGCACGCCACGCAGCGGATCAACACCGGCGATCTGATCGTCGTCGACGGGGACAGCGGGGTCGTGGAGATCATCGAGCCCGCAGCCGGGGGTGGTGCGTGA	MGPVARNATASSAVEPREVAGAGDDAARQGGKAARSRAKKAAGGDPSRKAPAAKAARRKTAAPSRRSPAGTSPAAEPPEPAAAAAGTRAPAPPADGHGPPTGPGTAAEPPARARAGASAAAPEAPSADVAVLGADAAAKPETLGGKAARLGEMIEAGFPVPPAVCLTTELFHRFLRETGLDKEIAGADRRTIRELVTGREIPAGIASVITGAYRGLGRPCVAVRSSAGRRTRPRSRSPGSTTRCSLTGDDAVLDAVRSCWASLWSDRAGVYHDSDGDNDGDSDGEGDGDSTGSTGAGSMAVVIQEMVQAEVSGVLFTVDPVSGREHRLVVEACRGLGEGLVSGRVSSDFFALDDRTFEVTERLIRYKVMKCAPVAPGQVGMEKVDAAARNAPCLTGGELRELAQLAVRVREHYGAEQDIEWALRDGELLLLQTRPITTVSAGAPPPAAAGARSPYVEEQPEDIQQGTMWSRMDIGEIFVGLMTPLGLSWARHHQRYVHGPCAASVGARDMGDPTRYMGYLQGHDNQNVSYHAHLLGQCPPTKNQEHFTRRFVSEEVDLDQYRNPFGAYPKGLKGLRSANFWARTTVAEMRGMAARAQHMATARLYEFDRSRALDLSLFDRRELHVELGRYLVNYHDMHVGYMPYYINAFGAYGLMTELCAKWLGDAGANLQNRLKMDMSSLRTVASAQDIWELTQAAQARPEVLRLIRETPLEKVADALLADVAGQEFWEGHLEPFLRENGVRGRQEMELTNPRWVDDPAYVFQMIRRYADDSTAVQEILARDRTTTGEDIEEVLARLPRMKRATLRKVIGLYIGNSTLREVARMAMVTSIWQVRNIVYEVARRLTEEGLLHSVDEVAYLEFQDIQRYLAGDEPARDIFTRERIDEAQRLHDYNNRLPEPPLTFMGEHDATRALQAAVAEAGTGLTGLGSSPGRITGRARIIEDLVWQADEFQVGEILVTRYTDASWTPLFAIAGGVVTDIGSMLSHSSIVSREFNVPSVVNTKHATQRINTGDLIVVDGDSGVVEIIEPAAGGGA	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	117.19	gnl|BL_ORD_ID|2235|hsp_num:0	2528			54	2649	rifampin; rifaximin; rifabutin; rifapentine
BGC0000257.1|Prodigiosin_21 # 33287 # 34543 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.674	BGC0000257.1|Prodigiosin_21 	33287	34543	+	Loose	300	28.4906	cpaA	32.43	3003994	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	cpa acetyltransferase	GTGCGTGAGGGGCGCCGCGGGCCCCCGCGCGGGCGCGGGCACCCCCGCGCCCCCGCACCCCAGGACCGGTACACCGTGCCGCACGCACAGCTGGACAGGAGTGACAGAGAAATGATCCCGAATCAGTGGTACGCCATCCTTCTGTCGGGGGATGTGAAGAAGAACAAACCGCACAAGACCCGGCGCATGGGCGAGAACCTCGTGGTGTGGCGGGACATCGAGGGGAAAGTGGTCTGCCAGCAGGCCAGGTGCCCGCACAAGGGCGCCAACCTCGCGGACGGCCGGGTCATGGGGAATTCCGTGGAATGCCCTTACCACGGTTTCCGGTTCGACCCCTCGGGGCAGTGCGTCGCGGTGCCCTGCCTGGGGACGGAGGCGCGTATTCCGCCCTCGATGCGGGTGAAGAGCTACCCCGTCCGCGAGCACCTCGGGCTCATCTGGATGTGGTGGGGCGAGGACCGCGAGGTACTGCCCGACCTCCCGATTCCGCAGGAAGTGGCGGAGAAGGAGAAGGAAGGCACATACGCGACGATGCGCTGGACCCGTCCGGTGCACTACACGCGTCATATCGAGAGCACGCTGGAGTTCTACCACATCACCTTCGTGCACCGGGGGCACTGGTTCAACTCCATCGACTACCTGTTCCTCTACGGCACCCCGGCCAAGCTGGGCCTGGACGGCCGCAAGCGCTACCTGGCGGCGACCAAGGTGGAGAACAACCACCTGGAGGTGGACGGCACCACCCTCCGCTACTCCTACGACCACCTGGAGGAGGGCACGAAGGCGAACTGCAACCACTACGACGTGATCTTCCAGTTCCCGCACATGACGCATGTGGCGAACAAGCAGTTCGAGGTCACCGCGTGGTTCGCGCCGATCGACGACCACAACACCGAGTTCATCCTGCGCTGGTACGAGTTCCCGCGGCTGCGGGGCATGCTGCGCGCCGAGCGGCTGCGGCGGCTGTTCCCTGCGGCCGGGCTGTACATGGAGAAGTGGATCCAGGACATGCAGGACGTCCGGGTGATCCAGGGCCAGCAGCCGCAGATCACGCAGCGCGGGGCGAGCAAGTTCGTGGCGGTGGACGAGCTGAACGCGAAGTACGTCTCGATGCGGGCGCAGCTCATCGCGGAGGCGAACGCCGGCACCGCGGGCGACGGCAAGGACAGCGCCGGGCGGGACGGCCGCGAACTGCGTGCCGCGGTGCCCGGGGGCACGGGCGCAAGCACCAACGGGCACACCCAACGGGCACCGTAA	MREGRRGPPRGRGHPRAPAPQDRYTVPHAQLDRSDREMIPNQWYAILLSGDVKKNKPHKTRRMGENLVVWRDIEGKVVCQQARCPHKGANLADGRVMGNSVECPYHGFRFDPSGQCVAVPCLGTEARIPPSMRVKSYPVREHLGLIWMWWGEDREVLPDLPIPQEVAEKEKEGTYATMRWTRPVHYTRHIESTLEFYHITFVHRGHWFNSIDYLFLYGTPAKLGLDGRKRYLAATKVENNHLEVDGTTLRYSYDHLEEGTKANCNHYDVIFQFPHMTHVANKQFEVTAWFAPIDDHNTEFILRWYEFPRLRGMLRAERLRRLFPAAGLYMEKWIQDMQDVRVIQGQQPQITQRGASKFVAVDELNAKYVSMRAQLIAEANAGTAGDGKDSAGRDGRELRAAVPGGTGASTNGHTQRAP	MPLRITAMTETYADQIMQWSYEPPYDFYNSEPDEEFRKELLECSYYAILDKEGQLFGFCCTGSSAQIPIAIPLGAYDEDLLDFGLGMKPESTGQCRGKEFLSFVLASIAEFHKRQSFRLTVAKFNERAIRLYTQLGFSEVATFDYGGTTFITMIKKPGSGL	259.63	gnl|BL_ORD_ID|2236|hsp_num:0	2529			120	228	capreomycin
BGC0000257.1|Prodigiosin_22 # 35304 # 35555 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=ACC;rbs_spacer=13bp;gc_cont=0.746	BGC0000257.1|Prodigiosin_22 	35304	35555	+	Loose	300	25.0238	dfrA6	26.53	3004547	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGAGGGTGGGCGCGACGATGAGCACGGCGTCGGGCCGCCGCTCGGCCGCCGAGCGGACGGCCTGCTGCCCCGAGGTCTCGGCGCTGACCTCCATGCCGCGCTGCTCCAGCAGCGCCCGCAGACCTGCGCTCATGATGGCGCGGTCACAGCACACCAGAACGCGGATGTTCGTCAAGGGACCAGGCCCCCTGCCGCGTTTTCCGTGGCCCGCAGGGCCGGCCGACGGCATCCCGGCGCCCGTCCCCCCGTAG	MRVGATMSTASGRRSAAERTACCPEVSALTSMPRCSSSARRPALMMARSQHTRTRMFVKGPGPLPRFPWPAGPADGIPAPVPP	MKISIMAAVSENGVIGSGLDIPWHVYGEQLLFKAMTYNHWLLVGRKTFDSMGKLPNRKYAVVTRTEMVSNDPDVVYFTSVESALAYLDHTTTHVFVSGGGEIYKALIEQADVIHLSVIHKHISGDVFFPSVPQSFKQTFEQSFSSNIDYTYQIWTKG	52.87	gnl|BL_ORD_ID|2702|hsp_num:0	3255			195	312	trimethoprim
BGC0000257.1|Prodigiosin_26 # 38085 # 38978 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.699	BGC0000257.1|Prodigiosin_26 	38085	38978	-	Loose	525	25.7942	OKP-D-1	39.53	3006153	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OKP beta-lactamase	ATGGCGTTCACCCTTCCGGCGACGGAGATCGAGGACCTGGAGGCACAGGTCCAGGCGGCGCTGCGGGCCGCCGACCACTCCGGGCTCACCGTGCTCGGGTACGGCGAGGTGTCCCTCGTGCTGGCGCTGGAGACCGGGGCAGGCAGCTTCGCCTGCAAGAGACTTCCCGTCTTCCCCGGTGCGGAGCAGCTGAAGACGTACGAGCGGTCGCTGGCCGAGTACATCCAGCGGCTGCGCGCCGCGGGCGTCACCGTCGCCGATTCCGACCTGTGGCACCGGCAGCTGCCCTCCGGCGGCACGGTGGCCTATGTGGTGCAGGAGGTGCTGCCCGCCAAGCGGCTGGTGTCGCAGCTGCTGCACAGCGAGGACGACGAGTGGGCGGAGGACTTCTTCACCCGGTTCCTGGACCGGGTGGAGGGTGCCGTGTCGCCGGTGCTCGGCCTGGACGCGCAGGCGTCCAACTGGGTGGATCTCGACGGCGAGCTGGTCTACCTGGACATCACCACGCCACTGATGCGGGATGCCCGCGGCCGTGAACGTCTCGACGTGCGGCTGTTCTACTCCTCGCTGCCCTGGGCGCTGCGCGATGTCACGCGGCTCACCATGACCGGTTCGATCCTGAACAAGTTCTACGAGCCGCGCGGCGTGGTGCTGGACTTCCTCGGCAACCTGCACAAGGAGCGGCTGAGCGCGCGGCTGCCCCGGTTCCTTGAGCAGGCCAATGCCCGGCTGCCGGGCAAGCCGATCACGGCGGACGAGGTGTCCGCGTACTACAAGGGCGACGCCCGCATGTGGGAGCTGCTCCAGCGGCTGCGCCGGGCCGACCGGCTCTGGCACCGGAAGATCCGGCGCCGGGTGTACCCGTTCCTGCTGCCGCCCGATGTCGCTCGCTGA	MAFTLPATEIEDLEAQVQAALRAADHSGLTVLGYGEVSLVLALETGAGSFACKRLPVFPGAEQLKTYERSLAEYIQRLRAAGVTVADSDLWHRQLPSGGTVAYVVQEVLPAKRLVSQLLHSEDDEWAEDFFTRFLDRVEGAVSPVLGLDAQASNWVDLDGELVYLDITTPLMRDARGRERLDVRLFYSSLPWALRDVTRLTMTGSILNKFYEPRGVVLDFLGNLHKERLSARLPRFLEQANARLPGKPITADEVSAYYKGDARMWELLQRLRRADRLWHRKIRRRVYPFLLPPDVAR	MRYVHLCVISLFACLPLPLFAGPQPLEQIKISESQLSGRVGYVEMDLASGRTLAAWRADERFPLTSTFKVLLCGAVLARVDAGVERLDRRIHYRQQDLVAYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLDTLGGPAGLTAFLRTIGDNVTRLDRRETQLNEALPGDVRDTTTPASMAATLRKLLTAKHLSARSQQQLVQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARGIVALLGPDGKAERIVVIYMRDTPATIAERNQQIAAIGAALIEHWQR	103.85	gnl|BL_ORD_ID|3724|hsp_num:0	4794			33	162	
BGC0000257.1|Prodigiosin_27 # 39050 # 39169 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.692	BGC0000257.1|Prodigiosin_27 	39050	39169	-	Loose	675	20.7866	emrA	34.62	3000027	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCTTCGCGGACCTCCGGATGGGCTCGCTCTCCGTGCGGGAGCTGCTCCTCGCCATCCAGACCGAATTCGGCGTACGGCGCGCGGCGGACCCGGGCGCGACATCCTGCCCTTCCTGA	MSFADLRMGSLSVRELLLAIQTEFGVRRAADPGATSCPS	MSANAETQTPQQPVKKSGKRKRLLLLLTLLFIIIAVAIGIYWFLVLRHFEETDDAYVAGNQIQIMSQVSGSVTKVWADNTDFVKEGDVLVTLDPTDARQAFEKAKTALASSVRQTHQLMINSKQLQANIEVQKIALAKAQSDYNRRVPLGNANLIGREELQHARDAVTSAQAQLDVAIQQYNANQAMILGTKLEDQPAVQQAATEVRNAWLALERTRIISPMTGYVSRRAVQPGAQISPTTPLMAVVPATNMWVDANFKETQIANMRIGQPVTITTDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDQKQLEQYPLRIGLSTLVSVNTTNRDGQVLANKVRSTPVAVSTAREISLAPVNKLIDDIVKANAG	10.00	gnl|BL_ORD_ID|1610|hsp_num:0	1757			642	720	nalidixic acid
BGC0000257.1|Prodigiosin_28 # 39949 # 40971 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.771	BGC0000257.1|Prodigiosin_28 	39949	40971	+	Loose	500	25.7942	AXC-4	27.12	3006900	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	AXC beta-lactamase	ATGACCCGGGCCGCGGTACTGGCCGGATTCGGCACCTGCCTGCCGGCCAGGCTCGTCACGAACGAGGAGCTCGCGGCGCGGGTGGGCCGCACCGACGCGTGGATACGCGCCCGCACCGGCATCGAGCGGCGGTACTTCGCGCCGGAGGGCACCTCCACCGCCGACCTGGCCACCGGCGCAGGCGCGCAGGCGCTGAAGTGCTCGGGCGTGCCGCAGGCCGACACCGTGGTGCTGGCCACCGTCACCCCTGACCGGCCGTGCCGCGCGGTCGCCCCCGTGGTGGCCTCCGGCCTCGGGCTGCACCAGGCCGCTGCGTACGACGTGTCCGCCGGCTTCGGCGGGTTCCTGTACGGCCTGGCCACGGCGGCCGGGCTGATCGGCTGCGGCGCCGCCGAACGTGCCCTGGTGATCGGCGCGGACACGCTCTCCCGGCGGCTCGACCCGGCCGACCGCCCCACCGCGGTCAGCTACGGCGACGGCGCCGGCGCGGTGCTGCTGCGGGCCGGCGAGCCGGACGAGCCGGGCGCACTGGGGCCCGTCTCGCTGGGCAGTGACGGGGAGGGCACGGGTGCCGTCTCGGTGCGGGACGGCGACGACACCGGCACCGCGCCCGCCGGCACCGCGCCCGCCGGCACCGCGCCCGGCCACCGGCCGGGCCGGTGGGCCGTCCGGGAGAACCGGCGCGCGTTCTGGCTCGGTGTGCAGCGCATGGCGCAGTCCGCGCAGTGCGTGCTGGACCGCGCGGGGTGGCCGGCGGGTGACGTCTCCCACCTGGTCACCCACCAGGCGAACCACCGGATCGTCGAACGCCTCGCCGACGAGCTGGGCATCCCGCGGGAGCGGGGCATCTGCAACATCTCCGAGGTGGGCAACACCGCCACGGCGTCCCTTCCGCTGACGCTCGGCCACGCCCATGCCGCGCGCCTGCCGAAGCCGGGCGACCGCGTGCTGCTCACCGCGTTCGGCGGCGGACTCACCTGGGGGGCGACGGTGCTCACCTGGCCGGCCATCGATCGGGACTGA	MTRAAVLAGFGTCLPARLVTNEELAARVGRTDAWIRARTGIERRYFAPEGTSTADLATGAGAQALKCSGVPQADTVVLATVTPDRPCRAVAPVVASGLGLHQAAAYDVSAGFGGFLYGLATAAGLIGCGAAERALVIGADTLSRRLDPADRPTAVSYGDGAGAVLLRAGEPDEPGALGPVSLGSDGEGTGAVSVRDGDDTGTAPAGTAPAGTAPGHRPGRWAVRENRRAFWLGVQRMAQSAQCVLDRAGWPAGDVSHLVTHQANHRIVERLADELGIPRERGICNISEVGNTATASLPLTLGHAHAARLPKPGDRVLLTAFGGGLTWGATVLTWPAIDRD	MLTRRTFIASAVLAGWIPALAHARTDKKTRWTRESLAAFQQGLAQVEAASRGRLGVALLDVGSGQAAGYRADERFLMLSSFKTLSAAYVLARADRGEDQLSRRIPITDADVREYSPVTRLHVGPRGMTLAELCEATITTSDNAAVNLMHKSYGGPQALTRYLRSLGDTVTRHDRYEPELNRPHPSEPQDTTTPQAMARTLDTLLFGDALKPQSRQQLQSWLLANTTGGKRLRAGMPADWKIGEKTGTYSKVGCNDAGFAQPPGAAPIIIAAYLETTAVPMEERDRCIAEVGRLVAAMG	114.09	gnl|BL_ORD_ID|3297|hsp_num:0	4366			219	396	
BGC0000257.1|Prodigiosin_29 # 41045 # 41323 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.616	BGC0000257.1|Prodigiosin_29 	41045	41323	+	Loose	600	26.9498	Acinetobacter baumannii AmvA	34.38	3004577	protein homolog model	n/a	n/a	macrolide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACTCCTCAGAATCTCATCTTCGACTACATCGCCGATGTGTGGATGGACGGTGACGCGGAGGGCCTGGAGGACGAGACGCCCATCGCCGAGCTGAACATCATCGACTCGGCCGGGATCTACGACCTGGTGCACTACCTCCAGGGTGAATTCCGGATCACCGTTCCCTTGCAGGACATCTCCCTGAAGAACTTCCGTTCCGTCAGCACGATCACGGCGCTCGTCGACCGCTTGCAGAAGGCGGACCGGGCGGCGGAAGAAGTGGGAGGGGCCGCCTGA	MTPQNLIFDYIADVWMDGDAEGLEDETPIAELNIIDSAGIYDLVHYLQGEFRITVPLQDISLKNFRSVSTITALVDRLQKADRAAEEVGGAA	MQKKWLILTIIVLIYLPVTIDATVMHVATPSLSAALNLTANQLLWIIDIYSLIMAGLILPMGALGDRIGFKKLLFIGTAVFGVGSLAAAFSPTAYALIASRAILGLGAAMLIPATLSGIRNAFTEEKQRNFALGIWSTVGGGGAAFGPLVGGFVLEHFHWGAVFLINIPIILAVLVMIVMIIPKQQEKTDQPINLGQALVLVVAILSLIYSIKSAMYNFSVLTVVMFVVGISTLIHFIRSQKRATTPMIDLELFKHPVISTSIVMAVVSMIALVGFELLLSQELQFVHGFSPLQAAMFIIPFMIAISLGGPLAGICLNKWGLRRVSSLGILVSALSLWGLAQLNFSTDHFLAWTCMVFLGFSIEIALLASTAAIMSSVPPQKASAAGAIEGMAYELGAGLGVAIFGLMLSWFYSRSIILPAELPSNLIEKASISIGETMQLASNLENPLGGQLIVVAQQAFSYAHSWVLTLSAICFFLLTVFVWFSFPKKVN	18.70	gnl|BL_ORD_ID|2718|hsp_num:0	3280			687	783	erythromycin; acriflavine
BGC0000257.1|Prodigiosin_30 # 41323 # 42489 # 1 # ID=1_30;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0000257.1|Prodigiosin_30 	41323	42489	+	Loose	400	25.0238	QnrB40	28.89	3002755	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ATGACCCACATCATGACCGACCGTCCGGACACCGGCGCGATCCACCGGCAGGTGCTGGACATCGTGGCGGCACGCACCCTGTACGACGAGACGCATCTGCTGCCGGACAGTCACTTCGAGGGTGAGCTCGGCATCGACTCGATCGTGCTGGAGTCCATCCTCTCCTCGGTGAAGGAGCACTTCGGCATCGTGGGCGGGCTGCCGCCCGGACTGTCCACGATCAGGGAACTGGTCGACGCGGTGGCGCACGCGCTGGGTGCCGCGCCGGGCGCGGGCGCCGCGGCGCCCGGCGCCGCCGGTGCGCCGGCGGAGGAAGCCGGCGGGCCCGCGCTGGACGCCGTGCTGGCCGCCGCCATGCGGCAGACCCAGTACCAGCGCCACCAGCTGGACCCCGACGCGGACTTCGAGGGCGAACTCGGCATCGACTCGGTGGTACTCGCCTCCGTCGTCGCCGAGGCCGCGCAGGCCCTCGGTATCCCGGACGGCAGGGCGGACGCCGGCGGCGCGACGACGCTGCGCGGGCTGGCCGCCGTGCTCGGCGCCGTGGCGGGGACGGAGGCGGGCACCACCGCGGAACCGAGACCGCCCGAGCCCGCCGCCGCGGCCCCCGGGCCCGCGGCCCCCGCGCCGGCCGCGGGCGGCGACCCCGGCTGGGACAGCCGTTCCATGAAGGACTTCGTGGAGCAGCGCGACCCGGACCTGTTCGCCAAGGCCCGCAGCTTCGCCGTGTACCGCCGCCGGCGCGAGGAGGAACAGCTCTACTGGTACGGCATGCCGATGCACTCGCGCAGCGAGAACCGTGCACTGATCCACGACGAACTGACCGGCCAGAAGCGCGACTTCCTGATGTTCGCCTCGAACAACTACCTCGGGCTCGCCACTCACCCGAAGGTCATCGAGGCCGTCTGCGACGTCACCCGCATCTACGGCTCCACGCACACCGGCTCCCGCATCATCGGCGGCACCAACCACCACCACCTGCACAAGGAACTGGAGCGGCGGCTCGCGGCGTTCAAACAGCGGCCCGCCTGCATCGTGTACCCCGGCGGGTACTCGGCCAACCTGGGCGCCATCTCGGCGCTGGTGAGGAGCTACGACACGCTGCTGGTCGACAAGCTCAACCATATGAGCATCGTGGACGGCGGCCGTCTCTCGGGCGGCAACCGG	MTHIMTDRPDTGAIHRQVLDIVAARTLYDETHLLPDSHFEGELGIDSIVLESILSSVKEHFGIVGGLPPGLSTIRELVDAVAHALGAAPGAGAAAPGAAGAPAEEAGGPALDAVLAAAMRQTQYQRHQLDPDADFEGELGIDSVVLASVVAEAAQALGIPDGRADAGGATTLRGLAAVLGAVAGTEAGTTAEPRPPEPAAAAPGPAAPAPAAGGDPGWDSRSMKDFVEQRDPDLFAKARSFAVYRRRREEEQLYWYGMPMHSRSENRALIHDELTGQKRDFLMFASNNYLGLATHPKVIEAVCDVTRIYGSTHTGSRIIGGTNHHHLHKELERRLAAFKQRPACIVYPGGYSANLGAISALVRSYDTLLVDKLNHMSIVDGGRLSGGNR	MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG	181.78	gnl|BL_ORD_ID|1163|hsp_num:0	1267			342	477	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000257.1|Prodigiosin_2 # 388 # 1848 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	BGC0000257.1|Prodigiosin_2 	388	1848	-	Loose	2300	26.1794	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin	31.15	3003283	protein variant model	S522L, H526T, G523A	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGCAGAGTGACAAGACCCTGCTGCTGGAGGTGGACCACGAGCAGGCGGACGCCTGCCGGCGTGCCATCGCGCCGTTCGCCGAGCTGGAGCGGGCGCCCGAGCACATCCACACCTACCGGGTGACCCCGCTGGGGCTGTGGAACGCGCGGGCCGCCGGGCACGACGCGGAGCAGGTGGTGGACGCGCTGGTCGCGCACTCCCGCTACCCGGTGCCGCACGCGCTGCTCGTCGATGTCGCCGAGACCATGGCCAGGTGCGGCAGGCTGCGGCTGCTCAAGCACCCGGTGCACGGTCTGGTGCTGGAGAGCTCCGACCGCCCGGTGCTGGAGGAGGTCCTGCGGTCGAAGAAGGTCCAGCCGCTGGTGGGCACCCGTATCGACCCGGACACGGTGGCGGTGCACCCGTCGGAGCGCGGGCAGATCAAGCAGACCCTGCTGCGGCTCGGCTGGCCCGCCGAGGACCTGGCGGGCTATGTGGACGGCGAGGCGCACCCCATCGCGCTGCACGAGGACGGCTGGGCGCTGCGGCCTTACCAGACGCAGGCGGTGGAGGGGTTCTGGCACGGCGGCTCCGGCGTGGTGGTGCTGCCGTGCGGGGCGGGCAAGACGCTGGTCGGCGCGGGGGCGATGGCGCAGGCGCGGGCGACCACGCTGATCCTGGTGACGAACACGGTGTCCGCCCGGCAGTGGAAGCACGAGCTGGTGCGCCGCACCTCGCTGACCGAGGACGAGATCGGCGAGTACAGCGGCACCCGCAAGGAGATCCGGCCGGTCACCATCGCCACGTACCAGGTGCTGACGGTGAAGCGGAAGGGGATCTACCCGCATCTGGAGCTGTTCGACTCGCGGGACTGGGGCCTGATCGTCTACGACGAGGTGCATCTGCTGCCGGCGGACTGCGTGGAGGTACGGGTCGACCTCACCGACGCGGAGCGGCTCGCCTACGCCACCGCGGAGACGGAGGAGAAGTACCGCTACTGTGCGACGACGGACACCAAGCGCCGGGTCACGGAGGCGCTGGTGCGGCGGCACGCGGGCGAGCAGACGCTGGTCATCGGGCAGTACATCGACCAGCTGGACGAGCTGGGCGAGCACATCGGGGCGCCCGTCATCAAGGGTGAGACCACGAACGCACGGCGCGAGAAGCTGTTCGAGGCGTTCCGGCAGGGCGAGCTGAGCGTGCTGGTGGTGTCGAAGGTGGCGAACTTCTCCGTCGACCTGCCGGAGGCGACGGTCGCGATCCAGGTGTCGGGCACCTTCGGGTCACGGCAGGAGGAGGCCCAGCGGCTGGGCCGGGTGCTGCGGCCGAAGGCAGACGGGCACGAGGCGCGGTTCTACTCGGTGGTGGCGCGGGACACGGTGGACCAGGACTACGCGGCGCACCGCCAGCGGTTCCTGGCGGAGCAGGGGTACGCGTACCGGATCGTGGACGCGACGGAGCTGCTGGCCGGCGAGGTGTAG	MQSDKTLLLEVDHEQADACRRAIAPFAELERAPEHIHTYRVTPLGLWNARAAGHDAEQVVDALVAHSRYPVPHALLVDVAETMARCGRLRLLKHPVHGLVLESSDRPVLEEVLRSKKVQPLVGTRIDPDTVAVHPSERGQIKQTLLRLGWPAEDLAGYVDGEAHPIALHEDGWALRPYQTQAVEGFWHGGSGVVVLPCGAGKTLVGAGAMAQARATTLILVTNTVSARQWKHELVRRTSLTEDEIGEYSGTRKEIRPVTIATYQVLTVKRKGIYPHLELFDSRDWGLIVYDEVHLLPADCVEVRVDLTDAERLAYATAETEEKYRYCATTDTKRRVTEALVRRHAGEQTLVIGQYIDQLDELGEHIGAPVIKGETTNARREKLFEAFRQGELSVLVVSKVANFSVDLPEATVAIQVSGTFGSRQEEAQRLGRVLRPKADGHEARFYSVVARDTVDQDYAAHRQRFLAEQGYAYRIVDATELLAGEV	MADSRQSKTAASPSPSRPQSSSNNSVPGAPNRVSFAKLREPLEVPGLLDVQTDSFEWLIGSPRWRESAAERGDVNPVGGLEEVLYELSPIEDFSGSMSLSFSDPRFDDVKAPVDECKDKDMTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTEKGTFIINGTERVVVSQLVRSPGVYFDETIDKSTDKTLHSVKVIPSRGAWLEFDVDKRDTVGVRIDRKRRQPVTVLLKALGWTSEQIVERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLRPGEPPTKESAQTLLENLFFKEKRYDLARVGRYKVNKKLGLHVGEPITSSTLTEEDVVATIEYLVRLHEGQTTMTVPGGVEVPVETDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRERMTTQDVEAITPQTLINIRPVVAAIKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGGLSRERAGLEVRDVHPSHYGRMCPIETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDGVVSDEIVYLTADEEDRHVVAQANSPIDADGRFVEPRVLVRRKAGEVEYVPSSEVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGDVVVAEESGVIEEVSADYITVMHDNGTRRTYRMRKFARSNHGTCANQCPIVDAGDRVEAGQVIADGPCTDDGEMALGKNLLVAIMPWEGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDTKLGAEEITRDIPNISDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDEDELPAGVNELVRVYVAQKRKISDGDKLAGRHGNKGVIGKILPVEDMPFLADGTPVDIILNTHGVPRRMNIGQILETHLGWCAHSGWKVDAAKGVPDWAARLPDELLEAQPNAIVSTPVFDGAQEAELQGLLSCTLPNRDGDVLVDADGKAMLFDGRSGEPFPYPVTVGYMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFKVLLKELQSLCLNVEVLSSDGAAIELREGEDEDLERAAANLGINLSRNESASVEDLA	41.47	gnl|BL_ORD_ID|1957|hsp_num:0	1237			1539	1722	rifampin; rifaximin; rifabutin; rifapentine
